JP5995232B2 - Efficient method for fusion of Neisseria gonorrhoeae cell lines - Google Patents

Efficient method for fusion of Neisseria gonorrhoeae cell lines Download PDF

Info

Publication number
JP5995232B2
JP5995232B2 JP2012065157A JP2012065157A JP5995232B2 JP 5995232 B2 JP5995232 B2 JP 5995232B2 JP 2012065157 A JP2012065157 A JP 2012065157A JP 2012065157 A JP2012065157 A JP 2012065157A JP 5995232 B2 JP5995232 B2 JP 5995232B2
Authority
JP
Japan
Prior art keywords
dna
aspergillus oryzae
aspergillus
fusion
sclr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2012065157A
Other languages
Japanese (ja)
Other versions
JP2013192537A (en
Inventor
勝ひこ 北本
勝ひこ 北本
潤一 丸山
潤一 丸山
龍太 和田
龍太 和田
小山 泰二
泰二 小山
鋒杰 金
鋒杰 金
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Tokyo NUC
Original Assignee
University of Tokyo NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Tokyo NUC filed Critical University of Tokyo NUC
Priority to JP2012065157A priority Critical patent/JP5995232B2/en
Publication of JP2013192537A publication Critical patent/JP2013192537A/en
Application granted granted Critical
Publication of JP5995232B2 publication Critical patent/JP5995232B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Description

本発明は、アスペルギルス・オリゼ等のアスペルギルス属細胞株の融合効率を高める方法、及び、アスペルギルス属細胞株の融合過程を簡便に解析する方法等に関する。   The present invention relates to a method for increasing the fusion efficiency of an Aspergillus cell line such as Aspergillus oryzae, a method for simply analyzing the fusion process of an Aspergillus cell line, and the like.

麹菌(アスペルギルス属菌)の一種であるアスペルギルス・オリゼAspergillus oryzae (A. oryzae)は我が国の伝統的な醸造製品である日本酒、味噌、醤油などの製造に古来1000年以上にわたって利用されている糸状菌であり、日本の「国菌」ともいわれている微生物である (Kitamoto, 2002)。また、世界保健機関 (WHO) および国際食糧農業機関 (FAO) によりA. oryzaeは安全性の高い菌として認められており (Barbesgaard et al., 1992)、食品・化成品・医療品向けの酵素剤および代謝化合物が国際的に広く流通している。また、優れたタンパク質分泌能力と安全性、さらには真核生物に共通する翻訳後修飾機構を有するA. oryzaeは、有用なタンパク質を大量生産するための宿主として使用されている(Ito et al., 2007; Nakajima et al., 2006; Tsuchiya et al., 1992, 1994)。 Aspergillus oryzae (A. oryzae), a type of Aspergillus spp., Is a filamentous fungus that has been used for more than 1000 years in the production of Japanese traditional sake, miso, and soy sauce. It is a microorganism that is said to be a “national fungus” in Japan (Kitamoto, 2002). In addition, A. oryzae is recognized as a highly safe bacterium by the World Health Organization (WHO) and the International Food and Agriculture Organization (FAO) (Barbesgaard et al., 1992), and is an enzyme for food, chemicals and medical products. Drugs and metabolic compounds are widely distributed internationally. In addition, A. oryzae, which has excellent protein secretion ability and safety, and a post-translational modification mechanism common to eukaryotes, is used as a host for mass production of useful proteins (Ito et al. , 2007; Nakajima et al., 2006; Tsuchiya et al., 1992, 1994).

A. oryzaeの遺伝子操作技術としては、1987年に形質転換系が開発され (Gomi et al., 1987)、今日までに、栄養要求性、薬剤耐性を利用した様々な選択マーカーが開発されてきた (Gomi et al., 1987; Kubodera et al., 2000; Mattern et al., 1987; Yamada et al., 1997)。金によりA. oryzaeの4重栄養要求性宿主・ベクター系も構築され、最大5種類の遺伝子を同時に導入もしくは破壊することが可能となっている(Jin et al., 2004b)。近年、非相同組換え修復に関与するligD遺伝子やku70遺伝子の破壊により、高頻度で相同組換えが可能な宿主株が作出され、遺伝子破壊株が容易に作製できるようになった (Takahashi et al., 2006; Escano et al., 2009; Mizutani et al., 2008; Maruyama and Kitamoto, 2008)。さらに、pyrGマーカーのリサイクリング技術による遺伝子の多重破壊も可能となった (Maruyama and Kitamoto, 2008)。マーカーリサイクリング技術により、プロテアーゼ遺伝子多重破壊株を作製し、異種タンパク質の生産量の向上に成功している (Yoon et al., 2009, 2011)。 As a genetic engineering technique for A. oryzae, a transformation system was developed in 1987 (Gomi et al., 1987), and various selection markers using auxotrophy and drug resistance have been developed to date. (Gomi et al., 1987; Kubodera et al., 2000; Mattern et al., 1987; Yamada et al., 1997). A four-auxotrophic host / vector system for A. oryzae has also been constructed using gold, and up to five genes can be introduced or destroyed simultaneously (Jin et al., 2004b). In recent years, disruption of the ligD gene and ku70 gene involved in non-homologous recombination repair has created host strains capable of high-frequency homologous recombination, making it easy to create gene-disrupted strains (Takahashi et al ., 2006; Escano et al., 2009; Mizutani et al., 2008; Maruyama and Kitamoto, 2008). In addition, multiple gene disruption using the pyrG marker recycling technology has become possible (Maruyama and Kitamoto, 2008). By using marker recycling technology, a protease gene multiple disruption strain has been created and the production of heterologous proteins has been successfully improved (Yoon et al., 2009, 2011).

A. oryzaeは有性世代が見つかっておらず、不完全菌 (Deuteromycete)として分類される。そして交配を行うことができず、複数の株の優良な表現型を備えた株の育種を効率的に行うことが困難である。また交配を用いた古典遺伝学を適用することが難しく、遺伝学的研究が遅れていた。 A. oryzae has no sexual generation and is classified as a Deuteromycete. And mating is not possible, and it is difficult to efficiently breed strains with excellent phenotypes of multiple strains. Moreover, it was difficult to apply classical genetics using mating, and genetic research was delayed.

しかしながら、近年ではゲノム解読の完了に伴いA. oryzaeも有性生殖をおこなう可能性が示されてきている (Machida et al., 2005; Galagan et al., 2005)。一方で、A. oryzaeにおいてRIP (Repeat-induced point mutation)が報告されている (Montiel et al., 2006)。RIPは、有性生殖時にゲノム上の異なる部位にある相同配列内においてC:GからT:Aへの塩基置換が生じる現象であり、他の糸状菌で有性世代の見つかっている菌株でも同様にRIPが報告されている (Braumann et al., 2008)。このことは、A. oryzaeが過去に有性生殖を行っていた可能性を示唆するものである。 In recent years, however, A. oryzae has been shown to be capable of sexual reproduction with the completion of genome decoding (Machida et al., 2005; Galagan et al., 2005). On the other hand, RIP (Repeat-induced point mutation) has been reported in A. oryzae (Montiel et al., 2006). RIP is a phenomenon in which base substitution from C: G to T: A occurs in homologous sequences at different sites on the genome during sexual reproduction, and the same applies to strains in which sexual generation is found in other filamentous fungi Reported RIP (Braumann et al., 2008). This suggests the possibility that A. oryzae had performed sexual reproduction in the past.

一方で、他のアスペルギルス属では有性世代が見つかっている。例えば、A. fumigatusや、A. oryzaeと非常に近縁であると考えられているA. flavusなどでは、それぞれ成熟した閉子嚢殻 (cleistothecium)もしくは菌核 (sclerotium)と呼ばれる構造体内部に子嚢胞子が存在することを確認している。ここで、菌核(sclerotium)は菌糸が融合を繰り返して密接した厚膜の小粒塊であり有性世代の構造である子嚢殻と似ている(Geiser, 2009; Dyer, 2007)。 On the other hand, sexual generations have been found in other Aspergillus species. For example, in A. fumigatus and A. flavus, which is considered to be very closely related to A. oryzae, inside a structure called mature cleistothecium or sclerotium, respectively. Confirms the existence of ascospores. Here, the sclerotium is a thick-filmed small particle mass in which mycelium is repeatedly fused and closely resembles the ascending shell which is a sexual generation structure (Geiser, 2009; Dyer, 2007).

これまでに有性世代が発見されているアスペルギルス属でA. oryzaeの祖先であるとされるA. flavusはA. oryzaeに比べ菌核の形成能が高いことが知られている(Murakami et al.,1971)。A. flavusが何らかの過程でその病原性などを家畜化の過程で失いA. oryzaeへと分化していったのではないかと近年では考えられており(Chang et al., 2010; 一島, 2003)、おそらくそうした進化の過程で菌核形成能も同様に失われていったのではないだろうかと予想される。一方でA. flavusの有性世代の発見は、子嚢胞子が成熟した菌核内に確認されたことにより明らかとなったが (Chang et al., 2010;Horn et al., 2009a)、A. oryzaeでも有性世代の発見は同様に菌核内に形成される子嚢胞子の確認によると考えられる。A. oryzaeはヘテロタリックな有性生殖を行う可能性が考えられており (Wada et al., 2012)、異なる接合型株の菌糸間の菌核形成後、その菌核内部で有性生殖が完了し、最終的に子嚢胞子が形成すると予想される。 A. flavus, an ancestor of A. oryzae in the genus Aspergillus that has been found to have a sexual generation, is known to have a higher ability to form sclerotia than A. oryzae (Murakami et al. ., 1971). In recent years, it has been thought that A. flavus lost its pathogenicity in the process of domestication and differentiated into A. oryzae (Chang et al., 2010; Ichishima, 2003) ) Probably, the ability to form nuclei was also lost in the course of such evolution. On the other hand, the discovery of the sexual generation of A. flavus was revealed by the confirmation of ascospores in the mature sclerotia (Chang et al., 2010; Horn et al., 2009a). The discovery of the sexual generation in oryzae is also thought to be due to the confirmation of ascospores formed in the sclerotia. A. oryzae is considered to be capable of heterothalic sexual reproduction (Wada et al., 2012) .After nucleation between mycelia of different zygotic strains, sexual reproduction occurs within the nuclei. It is expected to complete and eventually form ascospores.

従って、菌核形成の促進のための培養条件・因子の探索は重要な課題であると考えられており、培地成分の炭素/窒素比やアミノ酸組成などの条件が菌核形成に大きく影響することがこれまでに知られている他(McAlpin and Wicklow, 2005; Agnihotri, 1968)、植物病原菌(菌核病菌Sclerotinia sclerotiorum, 灰色かび病菌Botrytis cinereaなど)において分子レベルでの菌核の形成機構について研究が進められてきている。さらに、菌核組織内に特異的に発現するSsp1を、これらの植物病原菌と、Sclerotinia sclerotiorumなどから系統的に遠く離れたAspergillus属において菌核を形成するA. oryzaeとA. flavusが共有することも最新の研究で明らかになってきている (Amselem et al., 2011)。   Therefore, the search for culture conditions and factors for promoting nucleation is considered to be an important issue, and conditions such as the carbon / nitrogen ratio and amino acid composition of medium components have a significant effect on nucleation. Have been studied so far (McAlpin and Wicklow, 2005; Agnihotri, 1968). It has been advanced. In addition, Ssp1, which is specifically expressed in the mycorrhizal tissue, is shared by these plant pathogens and A. oryzae and A. flavus that form mycorrhiza in the genus Aspergillus that is systematically distant from Sclerotinia sclerotiorum Has also been clarified in the latest research (Amselem et al., 2011).

更に、Jinらはアスペルギルス属において高く保存されているbasic-helix-loop-helix型の新規転写因子SclR(Sclerotium regulator)をA. oryzaeで初めて同定しているが (Jin et al., 2009)、本転写因子SclRがA. oryzaeにおいて菌糸の形態制御にかかわっている可能性が示唆されていた(Jin et al., 2011)。さらに、SclR過剰発現は野生型株に比べ絡まりあった菌糸の形成促進によって、菌核の形成が促進されることもあわせて報告された (Jin et al., 2011)。 In addition, Jin et al. First identified a novel transcription factor SclR ( Scl erotium r egulator) of the basic-helix-loop-helix type highly conserved in Aspergillus in A. oryzae (Jin et al., 2009 ), It was suggested that this transcription factor SclR may be involved in the control of mycelial morphology in A. oryzae (Jin et al., 2011). Furthermore, overexpression of SclR was also reported to promote the formation of mycorrhiza by promoting the formation of entangled hyphae compared to the wild type strain (Jin et al., 2011).

上記のように、A. oryzaeでも菌核内で異なる接合型株の間で菌糸融合が繰り返され、それぞれの接合型株由来の核が同一細胞内に存在すれば、菌核内で核融合・減数分裂を経て子嚢胞子が形成されるのではないかと期待されるが、A. oryzaeでの有性生殖に関して菌核形成や菌糸融合に対する知見、及び、菌核形成と菌糸融合との関連性に関する知見は非常に乏しい。 As described above, even in A. oryzae, mycelial fusion is repeated between different zygotic strains in the sclerotia, and if nuclei from each zygote are present in the same cell, Ascospores are expected to form through meiosis, but knowledge about mycorrhizal formation and mycelial fusion in relation to sexual reproduction in A. oryzae, and the relationship between mycorrhizal formation and mycelial fusion The knowledge about is very scarce.

Jin FJ, Takahashi T, Matsushima K, Hara S, Shinohara Y, Maruyama J, Kitamoto K, & Koyama Y (2011) SclR, a basic helix-loop-helix transcription factor, regulates hyphal morphology and promotes sclerotial formation in Aspergillus oryzae. Eukaryot Cell 10: 945-955Jin FJ, Takahashi T, Matsushima K, Hara S, Shinohara Y, Maruyama J, Kitamoto K, & Koyama Y (2011) SclR, a basic helix-loop-helix transcription factor, regulates hyphal morphology and promotes sclerotial formation in Aspergillus oryzae. Eukaryot Cell 10: 945-955 Wada R, Maruyama J, Yamaguchi H, Yamamoto N, Wagu Y, Paoletti M, Archer DB, Dyer PS, & Kitamoto K (2012) Presence and Functionality of Mating-Type Genes in the Supposedly Asexual Filamentous Fungus Aspergillus oryzae. Appl Environ Microbiol in pressWada R, Maruyama J, Yamaguchi H, Yamamoto N, Wagu Y, Paoletti M, Archer DB, Dyer PS, & Kitamoto K (2012) Presence and Functionality of Mating-Type Genes in the Supposedly Asexual Filamentous Fungus Aspergillus oryzae.Appl Environ Microbiol in press

このようにヘテロタリックな種であるA. oryzaeにおいて有性生殖が開始されるためには、異なる接合型遺伝子を持つ株の細胞どうしが融合した後、同一細胞内に異なる株由来の核が存在する異核共存体(ヘテロカリオン)を形成し、その後さらに異なる接合型株由来の核が融合することが必須であると考えられ(Dyer, 2007)、有性生殖実験を行う際、有性生殖の完了を判別する手法が必要となってくる。更に、このような細胞株の融合効率を高めることが出来れば、基礎研究及び実用面で大きな貢献が期待できる。 In order to initiate sexual reproduction in this heterothallic species, A. oryzae, after cells of different mating type strains are fused, nuclei from different strains exist within the same cell. It is considered essential that a heterozygous heterozygote (heterokaryon) is formed, and then nuclei derived from different mating strains are fused (Dyer, 2007). It is necessary to have a method for discriminating completion. Furthermore, if the fusion efficiency of such cell lines can be increased, a great contribution can be expected in basic research and practical use.

本発明者は上記の課題を解決すべく鋭意研究の結果、これまでA. oryzaeにおいてほとんど観察・研究が行われてきていない細胞融合やヘテロカリオン形成に際して、菌糸融合実験や有性生殖実験を行う2株のうち一方の株にはウリジン/ウラシル要求性を付与し、かつ核を赤色蛍光で可視化し (H2B-mDsRed, ΔpyrG)、もう一方の株にはアデニン要求性を付与し、かつ核を緑色蛍光で可視化(H2B-EGFP, ΔadeB)することによって、細胞融合やヘテロカリオン形成を表現型に基づき、且つ、視覚的に容易に観察・同定できることを見出した。   As a result of diligent research to solve the above problems, the present inventor conducts mycelial fusion experiments and sexual reproduction experiments for cell fusion and heterokaryon formation, which has hardly been observed or studied so far in A. oryzae. One of the two strains is given uridine / uracil requirement and the nucleus is visualized with red fluorescence (H2B-mDsRed, ΔpyrG), the other strain is given adenine requirement and the nucleus is By visualizing with green fluorescence (H2B-EGFP, ΔadeB), we found that cell fusion and heterokaryon formation can be easily observed and identified visually based on phenotype.

更に、A. oryzaeにおける有性生殖の誘導を試みるため、A. flavusやA. oryzaeが有性生殖を行う場合に必須のプロセスであると考えられている菌核形成促進因子SclRを過剰発現させることによって上記株の作製過程で行い、菌糸(細胞)融合能が増大することが初めて確認された。 Furthermore, in order to attempt to induce sexual reproduction in A. oryzae, overexpression of the nucleation promoting factor SclR, which is considered to be an essential process when A. flavus and A. oryzae perform sexual reproduction As a result, it was confirmed for the first time that the mycelium (cell) fusion ability was increased in the process of producing the strain.

本発明は、以上の新たな知見に基づき成されたものである。
即ち、本発明は以下の態様を含むものである。
[態様1]2種類のアスペルギルス属細胞株(菌糸)の融合において、融合する該細胞株の少なくとも一方において菌核形成促進因子SclRの発現を増加させることにより、アスペルギルス属細胞株の融合効率を増加させる方法。
[態様2]アスペルギルス属細胞株がアスペルギルス・オリゼである、態様1の方法。
[態様3]プロモーター制御下に連結されたsclR遺伝子を含むプラスミドベクターでアスペルギルス属細胞株を形質転換することによって、該細胞株における菌核形成促進因子SclRの発現を増加させる、態様1又は2の方法。
[態様4]菌核内又は菌核の形成過程でアスペルギルス属細胞株(菌糸)の融合が行われる、態様1〜3のいずれかの方法。
[態様5]MEA培地を用い25℃・暗所・通気条件下でのアスペルギルス属細胞株の対峙培養においてアスペルギルス属細胞株(菌糸)の融合を行なわせる、態様1〜4のいずれかに記載の方法。
[態様6]更に、融合する2つのアスペルギルス属細胞株(菌糸)が夫々別の表現型により互いに識別可能な形質転換体であり、融合した細胞においては該表現型が相補されること、及び/又は、融合した細胞が2つの表現型を有することを基準として、融合細胞を同定する、態様1〜5のいずれかの方法。
[態様7]表現型が形質転換マーカー及び/又は標識物質の発現に基づくものである、態様6の方法。
[態様8]形質転換マーカーに基づく表現型が栄養要求性である、態様7の方法。
[態様9]融合した細胞においては該表現型が相補されることを、寒天CD最少培地における培養によって確認する、態様8の方法。
[態様10]標識物質が蛍光タンパク質である、態様7の方法。
[態様11]融合した細胞が2つの標識物質を有することを蛍光顕微鏡による核の観察によって確認する、態様10の方法。
[態様12]2種類のアスペルギルス属細胞株(菌糸)の融合において、融合する2つのアスペルギルス属細胞株が夫々別の表現型により互いに識別可能な形質転換体であり、融合した細胞においては該表現型が相補されること、及び/又は、融合した細胞が2つの表現型を有することを基準として融合細胞を同定する方法。
[態様13]以下の(a)、(b)、(c)、(d)又は(e)のDNAを含み、宿主であるアスペルギルス属細胞株への形質導入又は形質転換によって、該細胞株の融合効率を増加させる機能を有する組換えベクター:
(a)配列番号1で表される塩基配列からなるDNA、
(b)(a)の塩基配列からなるDNAと相補的な塩基配列からなるDNAとストリンジェントな条件下でハイブリダイズするDNAであって、アスペルギルス属細胞株の融合効率を増加させる機能を有するタンパク質をコードするDNA、
(c)(a)の塩基配列からなるDNAと90%以上の配列相同性を示す塩基配列からなるDNAであって、アスペルギルス属細胞株の融合効率を増加させる機能を有するタンパク質をコードするDNA、
(d)配列番号2で表されるアミノ酸配列からなるタンパク質をコードするDNA、又は
(e)(d)のアミノ酸配列において、1個若しくは数個のアミノ酸が欠失、置換、若しくは付加されたアミノ酸配列からなり、アスペルギルス属細胞株の融合効率を増加させる機能を有するタンパク質をコードするDNA。
[態様14]態様13記載の組換えベクターにより形質導入又は形質転換され、親株と比較して融合効率が増加されていることを特徴とするアスペルギルス属細胞株。
The present invention has been made based on the above new findings.
That is, the present invention includes the following aspects.
[Aspect 1] In the fusion of two Aspergillus cell lines (mycelia), the fusion efficiency of the Aspergillus cell line is increased by increasing the expression of the nucleation promoting factor SclR in at least one of the fused cell lines. How to make.
[Aspect 2] The method according to Aspect 1, wherein the Aspergillus cell line is Aspergillus oryzae.
[Aspect 3] The expression of the nucleation-promoting factor SclR in the cell line is increased by transforming an Aspergillus cell line with a plasmid vector containing a sclR gene linked under the control of a promoter. Method.
[Aspect 4] The method according to any one of Aspects 1 to 3, wherein the Aspergillus genus cell line (mycelium) is fused in the sclerotia or in the process of sclerotia formation.
[Aspect 5] The aspect according to any one of Aspects 1 to 4, wherein the Aspergillus cell line (mycelium) is fused in an opposing culture of the Aspergillus cell line at 25 ° C. in the dark and under aeration conditions using MEA medium. Method.
[Aspect 6] Further, two Aspergillus cell lines (mycelia) to be fused are transformants that can be distinguished from each other by different phenotypes, and the phenotypes are complemented in the fused cells, and / or Alternatively, the method according to any one of aspects 1 to 5, wherein the fused cell is identified based on the fact that the fused cell has two phenotypes.
[Aspect 7] The method according to Aspect 6, wherein the phenotype is based on the expression of a transformation marker and / or a labeling substance.
[Aspect 8] The method according to Aspect 7, wherein the phenotype based on the transformation marker is auxotrophy.
[Aspect 9] The method according to Aspect 8, wherein the phenotype is complemented in fused cells by culturing in an agar CD minimal medium.
[Aspect 10] The method according to Aspect 7, wherein the labeling substance is a fluorescent protein.
[Aspect 11] The method according to Aspect 10, wherein it is confirmed by observing a nucleus with a fluorescence microscope that a fused cell has two labeling substances.
[Aspect 12] In the fusion of two types of Aspergillus cell lines (mycelia), the two Aspergillus cell lines to be fused are transformants that can be distinguished from each other by different phenotypes. A method of identifying a fused cell based on the type being complementary and / or that the fused cell has two phenotypes.
[Aspect 13] The DNA of the following (a), (b), (c), (d) or (e) is contained, and the cell line is transformed by transduction or transformation into the host Aspergillus genus cell line. A recombinant vector having a function of increasing the fusion efficiency:
(A) DNA comprising the base sequence represented by SEQ ID NO: 1,
(B) a protein that hybridizes under stringent conditions with a DNA comprising a base sequence complementary to the DNA comprising the base sequence of (a) and having a function of increasing the fusion efficiency of an Aspergillus cell line DNA encoding,
(C) a DNA comprising a nucleotide sequence having a sequence homology of 90% or more with the DNA comprising the nucleotide sequence of (a), which encodes a protein having a function of increasing the fusion efficiency of an Aspergillus cell line,
(D) DNA encoding a protein consisting of the amino acid sequence represented by SEQ ID NO: 2, or (e) an amino acid in which one or several amino acids have been deleted, substituted, or added in the amino acid sequence of (d) A DNA encoding a protein comprising a sequence and having a function of increasing the fusion efficiency of an Aspergillus cell line.
[Aspect 14] An Aspergillus cell line, which is transduced or transformed with the recombinant vector according to Aspect 13 and has an increased fusion efficiency compared to the parent strain.

SclRの発現が増加した2種類の麹菌細胞株どうし、又は、どちらか一方でSclRの発現が増加した株を含む2種類の麹菌細胞株の組み合わせによる対峙培養において、境界線特異的に形成される菌核数が有意に上昇することが確認された。更に、菌核内の麹菌細胞株の栄養要求性の相補および蛍光顕微鏡による核の観察の結果から、異なる株の表現型が同一の株に現れたことから、境界線上に形成された菌核内もしくは菌核の形成過程で菌糸が融合したことが示された。 Boundary line-specific formation occurs in two types of gonococcal cell lines with increased expression of SclR or in combination with two types of gonococcal cell lines, including strains with increased expression of SclR. It was confirmed that the number of fungal nuclei was significantly increased. Furthermore, as a result of complementation of the auxotrophy of gonococcal cell lines in the sclerotia and observation of the nuclei by fluorescence microscopy, phenotypes of different strains appeared in the same strain. Alternatively, it was shown that the mycelium was fused during the formation of mycorrhiza.

NPlD-HR1 (H2B-mDsRed)の構築の概略を示す。An outline of the construction of NPlD-HR1 (H2B-mDsRed) is shown. NPlD-HG1 (H2B-EGFP) の構築の概略を示す。An outline of the construction of NPlD-HG1 (H2B-EGFP) is shown. 菌核形成促進因子SclR過剰発現株の作製の概略を示す.An outline of the production of a nucleation promoting factor SclR overexpression strain is shown. 菌核形成促進因子SclR過剰発現株に対するコントロール株の作製の概略を示す。An outline of production of a control strain for a strain overexpressing the nucleation promoting factor SclR is shown. 形質転換体におけるウリジン/ウラシル要求性からアデニン要求性への変換の過程を示す。The process of conversion from uridine / uracil requirement to adenine requirement in transformants is shown. CD最少培地を用いた栄養要求性の変換の確認の結果を示す。The result of the confirmation of the conversion of auxotrophy using CD minimum medium is shown. 栄養要求性が変換された株の染色体構造を示す。The chromosome structure of the strain | stump | stock in which auxotrophy was converted is shown. 栄養要求性が変換された株の系統図を示す。The systematic diagram of the strain | stump | stock in which auxotrophy was converted is shown. 菌核形成促進因子SclR過剰発現株とコントロール株における菌核の形成を示す。Fig. 2 shows the formation of sclerotia in a strain that overexpresses the sclerotium promotion factor SclR and a control strain. 菌核形成促進因子SclR過剰発現株とコントロール株との増殖の比較を示す。A comparison of growth between the nucleation-promoting factor SclR overexpression strain and the control strain is shown. 栄養要求性の異なる株の境界線上での菌核形成を示す。The sclerotial formation on the boundary line of strains with different auxotrophy is shown. 境界線特異的な菌核形成における菌核数を示す。The number of microbial nuclei in borderline specific nucleation is shown. CD最少培地での境界線特異的に形成された菌核内での栄養要求性の相補を示す。The complementation of auxotrophy in the sclerotia formed specifically on the border line in CD minimal medium is shown. 境界線特異的な菌糸融合を行ったと考えられる菌核数を示す。The number of myconuclei considered to have undergone boundary-specific hyphal fusion. 栄養要求性の異なる株の境界線特異的に形成された菌核のうちウリジン/ウラシルとアデニンを含まない寒天CD最少培地で生育を示した菌糸を蛍光顕微鏡で観察した結果を示す。The result of observing with a fluorescence microscope the mycelium which grew in the agar CD minimum culture medium which does not contain uridine / uracil and adenine among the mycelia specifically formed in the boundary line of the strain | stump | stock from which an auxotrophy differs is shown.

本発明は、2種類のアスペルギルス属細胞株(菌糸)の融合において、融合する該細胞株の少なくとも一方において菌核形成促進因子SclRの発現を増加させることにより、アスペルギルス属細胞株の融合効率を増加させる方法に関するものである。 In the fusion of two types of Aspergillus cell lines (mycelium), the present invention increases the fusion efficiency of the Aspergillus cell line by increasing the expression of the nucleation promoting factor SclR in at least one of the fused cell lines. It is about the method to make it.

菌核形成促進因子SclRは既に公知であり、sclR遺伝子の塩基配列(配列番号1)もAspergillus oryzaeゲノムデータベース等に開示されているので、当業者であれば、それらからSclRに関する情報を容易に入手することが出来る。   The nucleation-promoting factor SclR is already known, and the base sequence (SEQ ID NO: 1) of the sclR gene is also disclosed in the Aspergillus oryzae genome database, etc., so that those skilled in the art can easily obtain information on SclR from them. I can do it.

アスペルギルス属はおよそ250種の菌からなるが (Samson and Varga, 2010)、産業的に有用であるもの、逆にヒトや植物に対し病原性を有するものが多く含まれる。真菌類の生活環では一般に、有性胞子を形成する生活環と無性胞子を形成する生活環が見られるが、アスペルギルス属においてはその64%で有性生活環が見られず、無性生活環のみで生育している (Dyer et al., 2012)。有性生活環とは、単相核で過ごしていた個体が、核融合・減数分裂によって遺伝的に新たな個体を生じる過程のことをいう。これに対し、無性生殖とは体細胞分裂のみによって遺伝的に同一な個体を生じる過程のことを指す。 The genus Aspergillus consists of approximately 250 species of bacteria (Samson and Varga, 2010), but many of them are industrially useful, and conversely, many are pathogenic to humans and plants. In the life cycle of fungi, there are generally a life cycle that forms sexual spores and a life cycle that forms asexual spores, but in Aspergillus, 64% do not have a sexual life cycle and asexual life. It grows on rings only (Dyer et al., 2012). The sexual life cycle refers to a process in which an individual who has spent a single-phase nucleus generates a genetically new individual through fusion and meiosis. In contrast, asexual reproduction refers to the process of producing genetically identical individuals only through somatic division.

真菌類の分類は、有性生殖によってできる構造体(子実体、fruiting body)の形態をもとに行われているため、無性生活環のみが知られ有性生活環の見つかっていない菌は不完全菌として分類される。アスペルギルス属においては、A. nidulans、A. fumigatus、A. flavus、A. parasiticus、A. nomiusなどで有性生活環が見つかっているが、A. oryzaeを含め他のアスペルギルス属の大半が、分生子→菌糸→分生子を繰り返す無性生活環のみが知られており、不完全菌類として分類されている。 Fungi are classified based on the form of sexual reproduction structure (fruiting body), so that only the asexual life cycle is known and the sexual life cycle is not found Classified as imperfect bacteria. In the genus Aspergillus, sexual life cycles have been found in A. nidulans, A. fumigatus, A. flavus, A. parasiticus, A. nomius, etc., but most other Aspergillus species including A. oryzae Only the asexual life cycle that repeats the offspring → mycelium → conidia is known and classified as an incomplete fungus.

従って、本発明の方法に対象となるアスペルギルス属細胞株としては、アスペルギルス・オリゼのような、不完全菌として分類される菌株が好ましい。   Therefore, as the Aspergillus genus cell line targeted for the method of the present invention, a strain classified as an incomplete bacterium such as Aspergillus oryzae is preferable.

本発明方法において、細胞株における菌核形成促進因子SclRの発現を増加させる手段に特に制限はなく、当業者に公知の任意の方法で実施することが出来る。例えば、適当な構成的プロモーター又は誘導プロモーターの制御下で発現されるように該プロモーターに連結されたsclR遺伝子を含むプラスミドベクターで予めアスペルギルス属細胞株を形質転換することによって、該形質転換体においてSclRの発現を増加させることが可能である。 In the method of the present invention, the means for increasing the expression of the nucleation promoting factor SclR in the cell line is not particularly limited and can be carried out by any method known to those skilled in the art. For example, by transforming an Aspergillus cell line in advance with a plasmid vector containing a sclR gene linked to the promoter to be expressed under the control of a suitable constitutive or inducible promoter, the SclR in the transformant It is possible to increase the expression of

菌核は子嚢菌門および担子菌門に属する一部の糸状菌で観察され、無性的に形成される耐久性の休眠構造である(Willets and Bullock, 1992; Erentala et al., 2008)。菌糸が分岐・融合・接着を繰り返して密集し、メラニン沈着とともに硬壁化して形成される。直径は1〜3 mm程度であるが、直径3.5 cmを超えるものもある(Bolton et al., 2006)。外側から、メラニンに富む厚い着色細胞よりなる皮質rind、織り重なった菌糸よりなる髄質medullaとからなり、環境や栄養条件が良好であれば発芽する。 The mycorrhiza is a durable dormant structure that is asexually formed and is observed in some filamentous fungi belonging to Ascomycota and Basidiomycota (Willets and Bullock, 1992; Erentala et al., 2008). The hyphae are formed by repeatedly branching, fusing and adhering to form a hard wall with melanin deposition. The diameter is on the order of 1 to 3 mm, but some exceed 3.5 cm in diameter (Bolton et al., 2006). From the outside, it consists of cortical rind consisting of thick colored cells rich in melanin and medulla medulla consisting of woven hyphae, and germinates under good environmental and nutritional conditions.

本発明方法においては、このような菌核内又は菌核の形成過程でアスペルギルス属細胞株(菌糸)の融合が行われることが好ましい。 In the method of the present invention, it is preferable that the Aspergillus genus cell line (mycelium) is fused in such a sclerotia or in the process of sclerotia formation.

本発明方法においては、適当な条件下で2種類のアスペルギルス属細胞株(菌糸)を培養することによって、これら細胞株を融合させることができる。このような培養条件は、用いる細胞株の種類等に応じて当業者が適宜選択することが出来る。例えば、本明細書の実施例に記載されているように、MEA培地等の当業者に公知の培地を用い25℃〜30℃の温度で、暗所及び通気条件下で行うことが好ましい。又、培養方法としては、固体培地を用いる対峙培養及び液体培養等の当業者に公知の適当な方法を用いることが出来る。 In the method of the present invention, these cell lines can be fused by culturing two types of Aspergillus cell lines (mycelia) under appropriate conditions. Such culture conditions can be appropriately selected by those skilled in the art according to the type of cell line used. For example, as described in the Examples of the present specification, it is preferable to use a medium known to those skilled in the art such as MEA medium at a temperature of 25 ° C. to 30 ° C. in a dark place and under aeration conditions. In addition, as a culture method, an appropriate method known to those skilled in the art, such as counter culture using a solid medium and liquid culture, can be used.

本発明方法においては、更に、融合する2つのアスペルギルス属細胞株(菌糸)が夫々別の表現型により互いに識別可能な形質転換体であることが好ましい。こうすることによって、融合した細胞においては該表現型が相補されること、及び/又は、2つの表現型を有することを基準として、融合した2つのアスペルギルス属細胞株(菌糸)、即ち、これらの細胞株による異核共存体(ヘテロカリオン)の形成、及び/又は、その後の核の融合を簡便・容易に同定することが可能となる。従って、本発明は、2種類のアスペルギルス属細胞株(菌糸)の融合において、融合する2つのアスペルギルス属細胞株が夫々別の表現型により互いに識別可能な形質転換体であり、融合した細胞においては該表現型が相補されること、及び/又は、融合した細胞が2つの表現型を有することを基準として融合細胞を同定する方法にも関する。 In the method of the present invention, the two Aspergillus cell lines (mycelium) to be fused are preferably transformants that can be distinguished from each other by different phenotypes. In this way, two fused Aspergillus cell lines (mycelia), i.e., based on the fact that the phenotype is complemented in fused cells and / or has two phenotypes. Formation of heteronuclear coexistence (heterokaryon) by a cell line and / or subsequent fusion of nuclei can be easily and easily identified. Therefore, the present invention is a transformant in which two Aspergillus cell lines can be distinguished from each other by different phenotypes in the fusion of two types of Aspergillus cell lines (mycelia). It also relates to a method for identifying fused cells on the basis that the phenotypes are complemented and / or that the fused cells have two phenotypes.

このような表現型は、例えば、当業者に公知の任意の薬剤耐性マーカー及び栄養要求性マーカーを含めた多くの形質転換マーカーに基づく薬剤耐性及び栄養要求性、並びに、当業者に公知の任意の蛍光タンパク質等の標識物質の発現に基づくものである。例えば、栄養要求性マーカーの例として、アルギニン生合成経路に関わるargB遺伝子、ピリミジン生合成経路に関わるpyrG遺伝子、並びに、アデニン生合成経路に関わるadeA遺伝子及びadeB遺伝子等を挙げることができる。 Such phenotypes are, for example, drug resistance and auxotrophy based on a number of transformation markers, including any drug resistance marker and auxotrophic marker known to those skilled in the art, and any known to those skilled in the art. This is based on the expression of a labeling substance such as a fluorescent protein. Examples of auxotrophic markers include the argB gene related to the arginine biosynthesis pathway, the pyrG gene related to the pyrimidine biosynthesis pathway, and the adeA gene and adeB gene related to the adenine biosynthesis pathway.

本発明方法で用いる形質転換体は、本明細書の実施例に記載されているように、別の異なる2種類のこのような表現型を有していることが好ましい。 The transformant used in the method of the present invention preferably has two different types of such phenotypes as described in the examples of the present specification.

より具体的には、例えば、融合した2つのアスペルギルス属細胞株においては表現型(栄養要求性)が相補されることは寒天CD最少培地における培養において融合した細胞のみが生育できることを利用して確認することが出来る。 More specifically, for example, in two fused Aspergillus cell lines, complementation of the phenotype (auxotrophy) is confirmed using the fact that only fused cells can grow in culture on agar CD minimal medium. I can do it.

又、表現型が蛍光タンパク質であるような場合には、当業者に公知の標準的な方法に従がう蛍光顕微鏡による核の観察によって、2つのアスペルギルス属細胞株(菌糸)が融合したことを容易に確認することが可能である。 If the phenotype is a fluorescent protein, the two Aspergillus cell lines (mycelia) are fused by observing the nucleus with a fluorescence microscope according to standard methods known to those skilled in the art. It can be easily confirmed.

更に、本発明は、以下の(a)、(b)、(c)、(d)又は(e)のDNAを含み、宿主であるアスペルギルス属細胞株への形質導入又は形質転換によって、該細胞株の融合効率を増加させる機能を有する組換えベクターに関する:
(a)配列番号1で表される塩基配列からなるDNA、
(b)(a)の塩基配列からなるDNAと相補的な塩基配列からなるDNAとストリンジェントな条件下でハイブリダイズするDNAであって、アスペルギルス属細胞株の融合効率を増加させる機能を有するタンパク質をコードするDNA、
(c)(a)の塩基配列からなるDNAと90%以上の配列相同性を示す塩基配列からなるDNAであって、アスペルギルス属細胞株の融合効率を増加させる機能を有するタンパク質をコードするDNA、
(d)配列番号2で表されるアミノ酸配列からなるタンパク質をコードするDNA、又は
(e)(d)のアミノ酸配列において、1個若しくは数個のアミノ酸が欠失、置換、若しくは付加されたアミノ酸配列からなり、アスペルギルス属細胞株の融合効率を増加させる機能を有する活性を有するタンパク質をコードするDNA。
Furthermore, the present invention includes the following DNA (a), (b), (c), (d) or (e), and the cells can be obtained by transduction or transformation into a host cell line of Aspergillus. Recombinant vectors having the function of increasing the fusion efficiency of a strain:
(A) DNA comprising the base sequence represented by SEQ ID NO: 1,
(B) a protein that hybridizes under stringent conditions with a DNA comprising a base sequence complementary to the DNA comprising the base sequence of (a), and having a function of increasing the fusion efficiency of an Aspergillus cell line DNA encoding,
(C) a DNA consisting of a base sequence showing 90% or more sequence homology with DNA consisting of the base sequence of (a), which encodes a protein having a function of increasing the fusion efficiency of an Aspergillus cell line,
(D) DNA encoding a protein consisting of the amino acid sequence represented by SEQ ID NO: 2, or (e) an amino acid in which one or several amino acids have been deleted, substituted, or added in the amino acid sequence of (d) A DNA comprising a sequence and encoding a protein having an activity having a function of increasing the fusion efficiency of an Aspergillus cell line.

又、本発明は、上記の組換えベクターにより形質導入又は形質転換され、親株と比較して融合効率が増加されていることを特徴とするアスペルギルス属細胞株にも関する。 The present invention also relates to an Aspergillus cell line which is transduced or transformed with the above-described recombinant vector and has an increased fusion efficiency compared to the parent strain.

本発明における「配列番号1で表される塩基配列からなるDNA」は菌核形成促進因子SclRをコードしており、アミノ酸をコードする領域のみから成る塩基配列(すなわち、エクソン部分のみが結合された塩基配列)からなるcDNAも含まれる。このようなcDNAは、当業者に公知の任意の方法によって、本明細書に開示の塩基配列情報に基づき調製した適当なプライマーを用いて、麹菌のmRNAを鋳型としたPCR等により取得することが可能である。また、本発明のDNAは当業者に公知の任意の方法によって化学合成することも可能である。   The “DNA comprising the nucleotide sequence represented by SEQ ID NO: 1” in the present invention encodes the nucleation promoting factor SclR, and comprises a nucleotide sequence consisting only of the amino acid-encoding region (ie, only the exon part is bound). CDNA comprising a base sequence) is also included. Such cDNA can be obtained by PCR or the like using gonococcal mRNA as a template using an appropriate primer prepared based on the nucleotide sequence information disclosed in this specification by any method known to those skilled in the art. Is possible. The DNA of the present invention can also be chemically synthesized by any method known to those skilled in the art.

さらに、本発明のDNAには、上記DNAと相補的な塩基配列からなるDNAとストリンジェントな条件下でハイブリダイズするDNA、及び上記DNAと約90%以上、好ましくは約95%以上である配列相同性を示す塩基配列からなるDNAであって、アスペルギルス属細胞株の融合効率を増加させる機能を有するタンパク質をコードするDNAが含まれる。   Furthermore, the DNA of the present invention includes DNA that hybridizes under stringent conditions with DNA consisting of a base sequence complementary to the DNA, and a sequence that is about 90% or more, preferably about 95% or more with the DNA. DNA comprising a base sequence exhibiting homology, which encodes a protein having a function of increasing the fusion efficiency of an Aspergillus cell line.

ここで、ハイブリダイゼーションは、例えば、Molecular cloninng third.ed.(Cold Spring Harbor Lab.Press,2001)、又は、カレント・プロトコールズ・イン・モレキュラー・バイオロジー(Current protocols in molecular biology(edited by Frederick M. Ausubel et al.,1987)に記載の方法等、当業界で公知の方法あるいはそれに準じる方法に従って行うことができる。また、市販のライブラリーを使用する場合、添付の使用説明書に記載の方法に従って行うことができる。   Here, hybridization is performed by, for example, Molecular cloning third.ed. (Cold Spring Harbor Lab.Press, 2001), or Current protocols in molecular biology (edited by Frederick M Ausubel et al., 1987), etc., etc., which are known in the art, or a method analogous thereto, and when using a commercially available library, the method described in the attached instruction manual Can be done according to.

本明細書において、「ストリンジェントな条件下」とは、例えば、温度60℃〜68℃において、ナトリウム濃度15-900mM、好ましくは15-600mM、さらに好ましくは15-150mM、pH6-8であるような条件を挙げることができる。   In this specification, “stringent conditions” means, for example, at a temperature of 60 ° C. to 68 ° C., a sodium concentration of 15-900 mM, preferably 15-600 mM, more preferably 15-150 mM, pH 6-8. Can be mentioned.

従って、配列番号1で表される塩基配列を含むDNAと相補的な塩基配列からなるDNAとストリンジェントな条件下でハイブリダイズできるDNAとしては、例えば、該DNAの全塩基配列との相同性の程度が、全体の平均で、約90%以上、好ましくは約95%以上である塩基配列を含有するDNA等を挙げることができる。   Therefore, as a DNA that can hybridize under stringent conditions with a DNA comprising a base sequence complementary to the DNA comprising the base sequence represented by SEQ ID NO: 1, for example, the DNA having homology with the entire base sequence of the DNA Examples thereof include DNA containing a base sequence having a degree of about 90% or more, preferably about 95% or more in average on the whole.

本発明のタンパク質は、配列番号1で表される塩基配列からなるDNAにコードされるアミノ酸配列からなるタンパク質に加えて、このようなアミノ酸配列において、1個若しくは数個のアミノ酸が欠失、置換、若しくは付加されたアミノ酸配列(上記アミノ酸配列と配列相同性を有するアミノ酸配列)からなり、アスペルギルス属細胞株の融合効率を増加させる機能を有するタンパク質も含まれる。   In addition to the protein consisting of the amino acid sequence encoded by the DNA consisting of the base sequence represented by SEQ ID NO: 1, the protein of the present invention has one or several amino acids deleted or substituted in such an amino acid sequence. Or a protein comprising an added amino acid sequence (amino acid sequence having sequence homology with the above amino acid sequence) and having a function of increasing the fusion efficiency of an Aspergillus cell line.

2つの塩基配列又はアミノ酸配列における配列相同性を決定するために、配列は比較に最適な状態に前処理される。例えば、一方の配列にギャップを入れることにより、他方の配列とのアラインメントの最適化を行う。その後、各部位におけるアミノ酸残基又は塩基が比較される。第一の配列におけるある部位に、第二の配列の相当する部位と同じアミノ酸残基又は塩基が存在する場合、それらの配列は、その部位において同一である。2つの配列における配列相同性は、配列間での同一である部位数の全部位(全アミノ酸又は全塩基)数に対する百分率で示される。   In order to determine sequence homology between two base sequences or amino acid sequences, the sequences are pre-processed to the optimal state for comparison. For example, by making a gap in one sequence, the alignment with the other sequence is optimized. Thereafter, the amino acid residues or bases at each site are compared. When the same amino acid residue or base as the corresponding site in the second sequence is present at a site in the first sequence, the sequences are identical at that site. Sequence homology between the two sequences is expressed as a percentage of the total number of sites (all amino acids or all bases) of the number of sites that are identical between the sequences.

上記の原理に従い、2つの塩基配列又はアミノ酸配列における配列相同性は、例えば、Karlin及びAltschulのアルゴリズム(Proc.Natl.Acad.Sci.USA 87:2264-2268、1990及びProc.Natl.Acad.Sci.USA 90:5873-5877、1993)により決定される。このようなアルゴリズムを用いたBLASTプログラムやFASTAプログラムは、主に与えられた配列に対し、高い配列相同性を示す配列をデータベース中から検索するために用いられる。これらは、例えば、米国National Center for Biotechnology Informationのインターネット上のウェブサイトにおいて利用可能である。   In accordance with the above principles, sequence homology between two base or amino acid sequences can be determined, for example, by the algorithm of Karlin and Altschul (Proc. Natl. Acad. Sci. USA 87: 2264-2268, 1990 and Proc. Natl. Acad. Sci. USA 90: 5873-5877, 1993). A BLAST program or FASTA program using such an algorithm is mainly used to search a database for a sequence showing high sequence homology with a given sequence. These are available, for example, on the Internet website of the National Center for Biotechnology Information.

上記のような塩基配列の配列相同性又はコードするアミノ酸配列の配列相同性を示すようなDNAは、上記のようにハイブリダイゼーションを指標に得ることもでき、ゲノム塩基配列解析等によって得られた機能未知のDNA群又は公共データベースの中から、当業者が通常用いている方法により、例えば、前述のBLASTソフトウェアを用いた検索により発見することも容易である。さらに、本発明遺伝子は種々の公知の変異導入方法によって得ることもできる。   DNA that exhibits the sequence homology of the base sequence as described above or the sequence homology of the encoded amino acid sequence can also be obtained using hybridization as an index as described above, and functions obtained by genome base sequence analysis etc. It is also easy to find out from unknown DNA groups or public databases by a method commonly used by those skilled in the art, for example, by searching using the aforementioned BLAST software. Furthermore, the gene of the present invention can also be obtained by various known mutagenesis methods.

本発明の組換えベクターは、当業者に公知の適当な遺伝子工学的な手段を用いて、上記のDNAを適当なベクター内に連結することにより調製することができる。ベクターとしては、形質導入又は形質転換する宿主微生物のゲノム上の適当な位置に上記のDNAが挿入され、その緒果、親株と比較して、アスペルギルス属細胞株の融合効率を増加させることができるものであれば、その構造及び種類等に特に制限はない。例えば、プラスミド、コスミド、ファージ、ウイルス、染色体組み込み型、又は人工染色体等のベクターを用いることかできる。   The recombinant vector of the present invention can be prepared by ligating the above DNA into an appropriate vector using an appropriate genetic engineering means known to those skilled in the art. As a vector, the above DNA is inserted at an appropriate position on the genome of the host microorganism to be transduced or transformed, and as a result, the fusion efficiency of the Aspergillus cell line can be increased compared to the parent strain. If it is a thing, there will be no restriction | limiting in particular in the structure, a kind, etc. For example, vectors such as plasmids, cosmids, phages, viruses, chromosomal integration types, or artificial chromosomes can be used.

上記ベクターには、形質転換された細胞を選択することを可能にするために、AosCのような当業者に公知の任意のマーカー遺伝子が含まれていてもよい。また、組換えベクターは、宿主細胞中で本発明の遺伝子を発現することのできるプロモーター及びその他の制御配列(例えば、エンハンサー配列、ターミネーター配列、ポリアデニル化配列等)、さらに、目的とするDNAを挿入するためのマルチクローニングを含むことが望ましい。これらの組換えベクターに含まれる各要素は当業者に公知のものを適宜使用することが出来る。   The vector may contain any marker gene known to those skilled in the art, such as AosC, to allow selection of transformed cells. In addition, the recombinant vector is inserted with a promoter capable of expressing the gene of the present invention in a host cell and other control sequences (for example, an enhancer sequence, terminator sequence, polyadenylation sequence, etc.) and further the desired DNA. It is desirable to include multiple cloning to do this. As each element contained in these recombinant vectors, those known to those skilled in the art can be used as appropriate.

形質導入又は形質転換は、公知の適当な方法で行うことができる。例えば、プロトプラスト化した後ポリエチレングリコール及び塩化カルシウムを用いる方法(Mol.Gen.Genet.,218,99-104(1989))を用いることかできる。特に、実施例に記載されているような、Gatewayテクノロジーを使用することが好ましい。   Transduction or transformation can be performed by a known appropriate method. For example, a method using polyethylene glycol and calcium chloride after protoplastization (Mol. Gen. Genet., 218, 99-104 (1989)) can be used. In particular, it is preferred to use Gateway technology as described in the examples.

本発明の組換えベクターを形質導入又は形質転換されたアスペルギルス属細胞株は、菌核形成促進因子SclRの発現量が増大し、その結果、親株と比較してアスペルギルス属細胞株の融合効率が20%以上、好ましくは、2〜3倍になるような機能を意味する。尚、細胞株の融合効率は本明細書の実施例に示されるような方法で測定・評価することができる。   The Aspergillus cell line transduced or transformed with the recombinant vector of the present invention has an increased expression level of the nucleation promoting factor SclR. As a result, the Aspergillus cell line has a fusion efficiency of 20 compared to the parent strain. % Or more, preferably 2 to 3 times the function. The cell line fusion efficiency can be measured and evaluated by the method as shown in the examples of the present specification.

以下、実施例を用いて本発明をより詳細に説明するが、本発明の技術的範囲は以下の実施例に限定されるものではない。尚、本明細書に特に記載のない場合には、各種条件・手段・手法等は当該技術分野における技術的常識に従って当業者が適宜設定し実施することが可能である。 EXAMPLES Hereinafter, although this invention is demonstrated in detail using an Example, the technical scope of this invention is not limited to a following example. Unless otherwise specified in the present specification, various conditions, means, methods, and the like can be appropriately set and implemented by those skilled in the art according to technical common sense in the technical field.

核ヒストンH2B-mDsRedおよびH2B-EGFP融合タンパク質発現株による核の可視化
核の可視化のため、核ヒストンH2Bに赤色蛍光タンパク質mDsRedおよび緑色蛍光タンパク質EGFPをそれぞれ融合させた融合タンパク質を恒常的に発現するよう2つのプラスミドを設計した(pgHHDRS, pgHHGS; 図1A, 図2A)。形質転換用の選択マーカーにはA. oryzae由来のsC遺伝子 (以降AosCと記述)を用いた。
Nuclear visualization with nuclear histone H2B-mDsRed and H2B-EGFP fusion protein expression strains <br/> For nuclear visualization, a fusion protein consisting of nuclear histone H2B fused with red fluorescent protein mDsRed and green fluorescent protein EGFP, respectively. Two plasmids were designed to be expressed in (pgHHDRS, pgHHGS; FIG. 1A, FIG. 2A). As a selection marker for transformation, an sC gene derived from A. oryzae (hereinafter referred to as AosC) was used.

A. oryzae NSPlD1株(Maruyama and Kitamoto, 2008)にはpgHHDRSとpgHHGS両方のプラスミドをそれぞれ形質転換によりAosC遺伝子座にシングルコピーで挿入した (図1B, 図2B)。サザン解析にて、これらのプラスミドのAosC遺伝子座へのシングルコピーでの挿入を確認し、蛍光顕微鏡にてそれぞれの蛍光タンパク質による核の可視化を確認した(図1C, 図2C)。核が赤色蛍光タンパク質と緑色蛍光タンパク質で可視化された株をそれぞれNPlD-HR1 (H2B-mDsRed)、NPlD-HG1 (H2B-EGFP)と命名した。 In A. oryzae NSPlD1 strain (Maruyama and Kitamoto, 2008), both pgHHDRS and pgHHGS plasmids were inserted into the AosC locus in a single copy by transformation (FIGS. 1B and 2B). Southern analysis confirmed the single copy insertion of these plasmids into the AosC locus, and confirmed the visualization of nuclei by the respective fluorescent proteins with a fluorescence microscope (FIG. 1C, FIG. 2C). Strains whose nuclei were visualized with red fluorescent protein and green fluorescent protein were named NPlD-HR1 (H2B-mDsRed) and NPlD-HG1 (H2B-EGFP), respectively.

菌核形成促進因子SclR過剰発現株とコントロール株の作製
核の可視化によって得られたNPlD-HR1(H2B-mDsRed)およびNPlD-HG1(H2B-EGFP)の2種類の株のniaD遺伝子座に、amyBプロモーター下でSclRを過剰発現するためのプラスミド(pamy215;図3A)を挿入し、それぞれの株に対しSclRの過剰発現を試みた。形質転換の後、図3Bに示したコンストラクトによるサザン解析にてniaD遺伝子座にSclR過剰発現プラスミドがシングルコピーで挿入された株の取得を確認した。親株NPlD-HR1およびNPlD-HG1の2株に対し、取得したSclR過剰発現株をそれぞれPlD-HR1-sR (H2B-mDsRed, SclR OE)、PlD-HG1-sR (H2B-EGFP, SclR OE)と命名した。
Production of nucleation- promoting factor SclR overexpression strain and control strain <br/> niaD genes of two strains, NPlD-HR1 (H2B-mDsRed) and NPlD-HG1 (H2B-EGFP), obtained by visualization of the nucleus A plasmid (pamy215; FIG. 3A) for overexpressing SclR under the amyB promoter was inserted into the locus, and overexpression of SclR was attempted for each strain. After transformation, it was confirmed by Southern analysis using the construct shown in FIG. 3B that a strain in which the SclR overexpression plasmid was inserted at a single copy at the niaD locus was confirmed. The two SclR-overexpressing strains obtained from the parent strains NPlD-HR1 and NPlD-HG1 are PlD-HR1-sR (H2B-mDsRed, SclR OE), PlD-HG1-sR (H2B-EGFP, SclR OE) Named.

同様に核の可視化によって得られたNPlD-HR1およびNPlD-HG1の2種類の株のniaD遺伝子座に、amyBプロモーターのみを持つプラスミド(pUNA;図4A; Yamada et al., 1999)を挿入した、SclRの過剰発現に対するコントロール株の作製を試みた。形質転換の後、図4Bに示したコンストラクトによるサザン解析にてniaD遺伝子座にpUNAプラスミドがシングルコピーで挿入された株の取得を確認した。親株NPlD-HR1、およびNPlD-HG1の2株に対し、取得したコントロール株をそれぞれPlD-HR1-c (H2B-mDsRed, Ctrl)、PlD-HG1-c (H2B-EGFP, Ctrl)と命名した。 Similarly, a plasmid (pUNA; FIG. 4A; Yamada et al., 1999) having only the amyB promoter was inserted into the niaD locus of two strains of NPlD-HR1 and NPlD-HG1 obtained by nuclear visualization. An attempt was made to create a control strain for overexpression of SclR. After the transformation, it was confirmed by Southern analysis using the construct shown in FIG. 4B that a strain in which the pUNA plasmid was inserted in a single copy at the niaD locus was confirmed. The obtained control strains were named PlD-HR1-c (H2B-mDsRed, Ctrl) and PlD-HG1-c (H2B-EGFP, Ctrl) with respect to the two strains of parent strains NPlD-HR1 and NPlD-HG1, respectively.

栄養要求性の変換
ウリジン/ウラシル要求性からアデニン要求性への変換
A. oryzaeではこれまでに薬剤耐性マーカーや栄養要求性マーカーを含めた多くの形質転換マーカー、およびそれらを有するベクター系が開発されてきている。栄養要求性も前述のアルギニン生合成経路に関わるargB遺伝子やピリミジン生合成経路に関わるpyrG遺伝子、そのほかにもアデニン生合成経路に関わるadeA遺伝子やadeB遺伝子が栄養要求性マーカーとして開発されている (Jin et al., 2004a, 2004b; Kubodera et al., 2000)。これらの栄養要求性マーカー遺伝子のうち、adeA遺伝子は、NSPlD1株においては本来の第6染色体上のadeA遺伝子座と第3染色体上のargB遺伝子座にはUV照射による変異が導入されたadeA-遺伝子が存在し、正常に機能しているadeA遺伝子は最終的に第7染色体上のpyrG遺伝子座に存在している。煩雑化を防ぐためにも上項目のargB遺伝子以外に栄養要求性を付与できる遺伝子としてadeB遺伝子を用い、ΔpyrGでウリジン/ウラシル要求性株の第1染色体adeB遺伝子座に存在するadeB遺伝子をpyrG遺伝子により置換することで、ΔadeBでアデニン要求性に変換することにした。
Conversion of auxotrophy
Conversion from uridine / uracil requirement to adenine requirement
In A. oryzae, many transformation markers including drug resistance markers and auxotrophic markers and vector systems having them have been developed so far. As for auxotrophy, the argB gene related to the arginine biosynthesis pathway, the pyrG gene related to the pyrimidine biosynthesis pathway, and the adeA gene and adeB gene related to the adenine biosynthesis pathway have been developed as auxotrophic markers (Jin et al., 2004a, 2004b; Kubodera et al., 2000). Of these auxotrophic marker genes, ADEA gene in NSPlD1 strain mutated by UV irradiation was introduced into ADEA locus argB locus on chromosome 3 of the original chromosome 6 ADEA - Gene And the normally functioning adeA gene is finally present at the pyrG locus on chromosome 7. In order to prevent complications, the adeB gene is used as a gene that can confer auxotrophy in addition to the above argB gene, and the adeB gene present at the first chromosome adeB locus of uridine / uracil auxotrophic strain with ΔpyrG is expressed by the pyrG gene. By substituting, it was decided to convert to adenine requirement with ΔadeB.

上記で作製したPlD-HG1-sR株 (H2B-EGFP, SclR OE, ΔpyrG)とコントロール株であるPlD-HG1-c株 (H2B-EGFP, Ctrl, ΔpyrG)の第1染色体上にあるadeB遺伝子を、図5Aに示したadeB遺伝子の上流1.0 kb、下流1.0 kb およびpyrG遺伝子を含むDNA断片を用いてpyrG遺伝子により置換することでウリジン/ウラシル要求性をアデニン要求性へ変換した株を作製した。サザン解析により目的の遺伝子置換を確認し (図5B)、さらにCD最少培地を用いて栄養要求性の変換を確認した (図6)。取得したアデニン要求性の株をそれぞれAblD-HG1-sR (H2B-EGFP, SclR OE, ΔadeB)、AblD-HG1-c (H2B-EGFP, Ctrl, ΔadeB)と命名した。 The adeB gene on chromosome 1 of the PlD-HG1-sR strain (H2B-EGFP, SclR OE, ΔpyrG) and the control strain PlD-HG1-c strain (H2B-EGFP, Ctrl, ΔpyrG) A strain in which uridine / uracil requirement was converted to adenine requirement was prepared by replacing the DNA fragment containing 1.0 kb upstream and 1.0 kb downstream of the adeB gene and the pyrG gene shown in FIG. 5A with the pyrG gene. The target gene replacement was confirmed by Southern analysis (FIG. 5B), and the conversion of auxotrophy was confirmed using a CD minimal medium (FIG. 6). The obtained adenine-requiring strains were named AblD-HG1-sR (H2B-EGFP, SclR OE, ΔadeB) and AblD-HG1-c (H2B-EGFP, Ctrl, ΔadeB), respectively.

adeB遺伝子の上流1.0 kbおよび下流1.0 kbはそれぞれ前後の遺伝子(AO090009000332およびAO090009000334)のORFの一部を含む。そのため、adeB遺伝子のpyrG遺伝子での置換により取得した株に意図しない変異が入る可能性も考えられる。そこでAblD-HG1-sR、AblD-HG1-cの染色体DNA上のadeB遺伝子上流・下流それぞれ1.0 kbの領域における変異の有無をシーケンスにより確認した。その結果、形質転換による上記領域への変異は確認されなかった。図7と図8には上記で作製した株の染色体構造と、系統図を示した。 The upstream 1.0 kb and downstream 1.0 kb of the adeB gene each contain a part of the ORF of the preceding and succeeding genes (AO090009000332 and AO090009000334). Therefore, there is a possibility that an unintended mutation may be introduced into the strain obtained by replacing the adeB gene with the pyrG gene. Therefore, the presence or absence of mutations in the 1.0 kb region upstream and downstream of the adeB gene on the chromosomal DNA of AblD-HG1-sR and AblD-HG1-c was confirmed by sequencing. As a result, no mutation was confirmed in the region due to transformation. 7 and 8 show the chromosomal structure and systematic diagram of the strain prepared above.

SclR過剰発現株の菌核形成における培地条件の最適化
amyBプロモーター下でのSclR過剰発現をおこなった株の菌核形成に適した培地条件を検討した。他のアスペルギルス属でA. parasiticusや、A. oryzaeと近縁であるA. flavusでは有性生殖の誘導にMCA (Mixed Cereal Agar; 幼児の離乳食用のシリアルを水に溶かし寒天を加えたもの)培地を用いて異なる接合型どうしで対峙培養を行うことで有性世代の発見に至っている (O’Gorman et al., 2009; Horn et al., 2009a, 2009b; 実験材料及び方法)。一方でJinらは菌核形成促進因子SclRの同定およびその機能解析にマルツエキスを含むMEA (Malt Extract Agar)培地を用いている。そこで、これらの培地にPD培地を加えたMCA培地、MEA培地およびPD培地の3つの培地にSclR過剰発現株とコントロール株それぞれの分生子懸濁液を植菌し暗所・通気条件で培養した。この際、それぞれの寒天培地に植菌する分生子数を103個/5μlとしたが、これは植菌する分生子数が多すぎると菌核形成数が減少するというA. flavusやA. parasiticusで報告されている実験結果に基づいている (Brown et al., 2008, 2009)。2週間ほど培養したところ、成熟した黒色の菌核の形成数はMEA培地で最も多く、PD培地でも多少の菌核は形成される傾向を示した (図9)。これはマルツエキスに含まれるマルトースによりamyBプロモーター下のSclRの発現が強力に誘導されたためだと考えられる。また30℃と25℃のそれぞれの温度で暗所・通気条件での菌核形成を比較したところ、PD培地とMCA培地では変化はあまり見られなかったが、MEA培地においては25℃での培養では分生子形成が抑えられ菌核の形成数の上昇が観察された。また同様の条件で20℃以下ではどの培地でも菌核はほとんど形成されなかった。
以上の結果から、菌核形成を促進させ有性生殖を誘導し、さらにA. oryzaeの菌糸融合能におけるSclRの効果を評価するため、MEA培地を用い25℃・暗所・通気での培養条件を用いることとした。
Optimization of medium conditions for nucleation of SclR overexpressing strains
The culture medium conditions suitable for sclerotia formation of the strain which overexpressed SclR under the amyB promoter were examined. In other Aspergillus species, A. parasiticus and A. flavus, which is closely related to A. oryzae, MCA (Mixed Cereal Agar; baby cereal for infants dissolved in water and agar added) The sexual generation has been discovered by culturing different mating types using culture media (O'Gorman et al., 2009; Horn et al., 2009a, 2009b; experimental materials and methods). On the other hand, Jin et al. Used MEA (Malt Extract Agar) medium containing malt extract for the identification and functional analysis of the nucleation promoting factor SclR. Therefore, the conidial suspensions of the SclR overexpressing strain and the control strain were inoculated into three media, MCA medium, MEA medium and PD medium with PD medium added to these media, and cultured in the dark and aerated conditions. . At this time, although the number of conidia which inoculate each agar medium with 10 3/5 [mu] l, A. flavus and that this is the number of conidia inoculation amount is too large sclerotium formation speed is reduced A. Based on experimental results reported in parasiticus (Brown et al., 2008, 2009). When cultured for about 2 weeks, the number of mature black sclerotia formed was highest in the MEA medium, and some nuclei tended to be formed in the PD medium (FIG. 9). This is thought to be because the expression of SclR under the amyB promoter was strongly induced by maltose contained in malt extract. In addition, when comparing the nucleation in the dark and aerated conditions at 30 ° C and 25 ° C, there was little change in PD and MCA media. Then, conidia formation was suppressed and an increase in the number of mycorrhizal formation was observed. Under the same conditions, sclerotia was hardly formed in any medium at 20 ° C or lower.
Based on the above results, in order to promote sclerotia formation and induce sexual reproduction, and to evaluate the effect of SclR on the mycelial fusion ability of A. oryzae, culture conditions at 25 ° C, dark place, and aeration using MEA medium It was decided to use.

SclR過剰発現株を用いた表現型解析
アスペルギルス属ではA. flavusなどで分生子形成と菌核形成の間には負の相関があることが示唆されている (Brown et al., 2008, 2009)。ΔpyrG (ウリジン/ウラシル要求性)の株において、SclR過剰発現株とコントロール株の間で分生子形成量を比較したところ、PD培地ではコントロール株がSclR過剰発現株に比べ約7倍の分生子を形成した。また、SclR過剰発現株のほうがコロニーの形成速度が低下していた。コロニー形成速度の低下はCD培地でより顕著であった。炭素源にグルコースを用いたCD最少培地では生育初期(30℃、3日培養)の段階でコントロール株に比べSclR過剰発現株の生育が若干低下し、炭素源にマルトースを用いたCD最少培地では同様の生育初期の段階でコントロール株に比べSclR過剰発現株の生育が顕著に低下していることが観察された (図10)。またΔadeB (アデニン要求性)の株においても同様の結果が得られたが、ΔpyrGのSclR過剰発現株にくらべΔadeBのSclR過剰発現株が形成する菌核数は若干減少しており、また白色の菌核から黒色の菌核に成熟しないものが多かった。アデニン生合成の経路を途中で阻害することでアデニン要求性を付与しているが、このアデニン生合成経路が菌核の色の変化などに影響を及ぼしている可能性が考えられた。
Phenotypic analysis using SclR overexpressing strains In Aspergillus spp., There is a negative correlation between conidia formation and fungal nucleation in A. flavus etc. (Brown et al., 2008, 2009) . In the ΔpyrG (uridine / uracil auxotrophic) strain, when the conidia formation amount was compared between the SclR overexpressing strain and the control strain, the control strain showed about 7 times more conidia in the PD medium than the SclR overexpressing strain. Formed. In addition, the SclR overexpression strain had a lower colony formation rate. The decrease in colony formation rate was more pronounced with CD medium. In the CD minimal medium using glucose as the carbon source, the growth of the SclR-overexpressing strain was slightly reduced compared to the control strain at the early stage of growth (30 ° C, 3 days culture), and in the CD minimal medium using maltose as the carbon source. It was observed that the growth of the SclR-overexpressing strain was remarkably reduced compared to the control strain at the same early stage of growth (FIG. 10). Similar results were also obtained in the ΔadeB (adenine-requiring) strain, but the number of nuclei formed by the SclR overexpressing strain of ΔadeB was slightly decreased compared to the ΔclrG SclR overexpressing strain. There were many things that did not mature from sclerotia to black sclerotia. The adenine biosynthetic pathway is inhibited in the middle of the process, and adenine auxotrophy is conferred. It is considered that this adenine biosynthetic pathway may affect the change in the color of the sclerotia.

栄養要求性の異なる株の境界線上での菌核形成におけるSclR過剰発現の効果
境界線特異的な菌核の形成
上記で作製したSclR過剰発現株とコントロール株のうち、ΔpyrGでウリジン/ウラシル要求性を持ち核が赤色蛍光で可視化されている株、ΔadeBでアデニン要求性を持ち核が緑色蛍光で可視化されている細胞株を用いた。MEA培地に異なる栄養要求性を持つ株どうし、且つSclR過剰発現株どうしとコントロール株どうしが向き合うように25℃暗所・通気条件で対峙培養した (図11A)。培養7日ほどでそれぞれの株はコロニー内に黒色もしくは白色の菌核を形成し始める。そして培養14日ほどで異なる栄養要求性を持つ株の境界線特異的な菌核の形成が観察された (図11B、赤線内)。境界線上に形成された菌核はコロニー内部に形成された菌核に比べ形成が観察され始めた時期が遅く、またサイズも若干大きいものが多く観察された。またコロニー内部に形成された菌核は培養初期およそ7日で黒色に成熟したのに対し、1ヶ月以上の長期培養を行っても、境界線上に特異的に形成された菌核は白色のままであった。
Effect of SclR overexpression on nucleation on the boundary of strains with different auxotrophy
Boundary-specific nuclei formation Among the SclR overexpressing strains and control strains prepared above, ΔpyrG has uridine / uracil requirement and nuclei are visualized with red fluorescence, ΔadeB has adenine requirement A cell line whose nuclei were visualized with green fluorescence was used. The strains having different auxotrophy in the MEA medium, and the SclR overexpressing strains and the control strains were face-to-face cultured at 25 ° C. in a dark place at aeration (FIG. 11A). After about 7 days of culture, each strain begins to form black or white sclerotia in the colony. Then, the formation of microbial nuclei specific to the boundary line of strains having different auxotrophy was observed after about 14 days of culture (FIG. 11B, red line). The microbial nuclei formed on the boundary line were observed to form later than the microbial nuclei formed inside the colony, and many of them were slightly larger in size. In addition, the sclerotia formed inside the colony matured black in about 7 days in the initial culture, whereas the nuclei specifically formed on the boundary remained white even after long-term culture for more than 1 month. Met.

境界線特異的な菌核形成におけるSclR過剰発現の効果
図11BではSclR過剰発現株どうしの境界線と、コントロール株どうしの境界線に形成される菌核数に違いが観察された (図11B, 赤線内)。よって次に図12に示した株の組み合わせで境界線特異的に形成される菌核数を比較した。その結果、コントロール株どうしの組み合わせに比べ、過剰発現株どうしかもしくはどちらか一方が過剰発現株を含む組み合わせでは境界線特異的に形成される菌核数が有意に上昇した (図12)。
Effect of SclR overexpression on borderline-specific nucleation In FIG. 11B, a difference was observed in the number of nuclei formed between the borderline between SclR overexpressing strains and the borderline between control strains (FIG. 11B, (In red line). Therefore, the number of fungal nuclei specifically formed at the boundary line in the combination of strains shown in FIG. 12 was compared. As a result, compared to the combination of the control strains, the number of bacterial nuclei formed specifically in the boundary line was significantly increased in the case of the overexpression strain or the combination containing either of the overexpression strains (FIG. 12).

境界線特異的に形成された菌核内での栄養要求性の相補
CD最少培地での栄養要求性の相補の確認
それぞれの株のコロニー内に形成される菌核とは異なり、異なる栄養要求性を持つ株の境界線特異的に形成された菌核はそれぞれの株の菌糸どうしが密接に絡み合い形成されている。その菌核内部では異なる栄養要求性を持つ株の菌糸どうしの一部が融合していることも予想される。もし仮にこれらの菌核内で菌糸・細胞が融合して異なる栄養要求性を持つ株の菌糸間でヘテロカリオンが形成されれば、栄養要求性が相補される可能性が予測される。そこで、過剰発現株どうし・コントロール株どうしそれぞれの境界線特異的に形成された菌核をウリジン/ウラシルとアデニンを含まない寒天CD最少培地にシフトしたところ、シフトした菌核を中心にコロニー・菌糸成長が認められた (図13)。また各株のコロニー内部からシフトした菌核は菌糸成長を示さなかった (図13)。このことから、境界線上に形成された菌核内もしくは菌核形成の過程で菌糸が融合していることが示唆された。しかし、過剰発現株どうしとコントロール株どうしで、それぞれの境界線で形成された菌核のうち培地シフト後に菌糸成長を示す菌核の数に差が観察された (図13)。
Complementation of auxotrophy within the sclerotia formed specifically at the borderline
Confirmation of complementation of auxotrophy in CD minimal medium <br/> Unlike the sclerotia formed in the colonies of each strain, the sclerotia formed specifically on the borderline of strains with different auxotrophy Are closely intertwined with each other's hyphae. It is also expected that some of the mycelia of strains with different auxotrophy are fused inside the mycorrhiza. If the mycelium and cells in these mycelium are fused to form heterokaryons between mycelia of strains having different auxotrophy, the possibility that the auxotrophy is complemented is predicted. Therefore, when the sclerotia specifically formed between the overexpressing strains and between the control strains was shifted to an agar CD minimal medium not containing uridine / uracil and adenine, colonies and hyphae centered on the shifted sclerotia. Growth was observed (Figure 13). In addition, the mycorrhiza shifted from the inside of the colonies of each strain did not show hyphal growth (FIG. 13). From this, it was suggested that the mycelium was fused in the sclerotia formed on the boundary line or in the process of nucleation. However, a difference was observed in the number of fungal nuclei that showed hyphal growth after the medium shift among the overlying strains and the control strains among the bacterial nuclei formed at each boundary line (FIG. 13).

そこで、境界線特異的に形成された菌核を1つのプレートあたり8個ランダムに選び、ウリジン/ウラシルとアデニンを含まない寒天CD最少培地にシフトした。そして置換した8個の菌核のうちいくつが栄養要求性の相補により菌糸成長が可能となったかを指標に、菌糸融合効率の評価を行った。その結果、菌核内部もしくは菌核の形成過程で菌糸融合を行ったと考えられる菌核数は、コントロール株 x コントロール株の組み合わせに比べ、他の組み合わせでは20%ほど有意に効率が上昇することが示唆された (図14)。 Therefore, 8 bacterial nuclei formed specifically on the borderline were randomly selected per plate and shifted to agar CD minimal medium without uridine / uracil and adenine. Then, the mycelial fusion efficiency was evaluated by using as an index how many of the eight fungal nuclei that were replaced became capable of hyphal growth by complementation of auxotrophy. As a result, the number of fungal nuclei considered to have undergone mycelial fusion within the fungal nucleus or in the process of forming the fungal nucleus may be significantly increased by about 20% in other combinations compared to the control strain x control strain combination. Suggested (Figure 14).

蛍光顕微鏡による核の観察
作製したSclR過剰発現株とコントロール株のうち、ΔpyrGでウリジン/ウラシル要求性を持ち核が赤色蛍光で可視化されている株、ΔadeBでアデニン要求性を持ち核が緑色蛍光で可視化されている株を用いている。前項では、栄養要求性の相補が確認されたことで、異なる栄養要求性を持つ株の境界線上に形成された菌核内部もしくは菌核の形成過程で菌糸融合が行われたことが示唆された。接合型の組み合わせ、およびSclR過剰発現株とコントロール株のそれぞれの組み合わせで、栄養要求性の異なる株の境界線特異的に形成された菌核のうち、図13でウリジン/ウラシルとアデニンを含まない寒天CD最少培地で生育を示した菌糸を蛍光顕微鏡で観察した。その結果、大多数の菌糸においては、1つの菌糸中の核の色が赤色及び緑色両方の蛍光で観察された (図15)。
Observation of nuclei with fluorescence microscope Among SclR overexpressing strains and control strains prepared, strains that have uridine / uracil requirement with ΔpyrG and nuclei are visualized with red fluorescence, those with adenine requirement with ΔadeB and nuclei with green fluorescence The strain that is visualized is used. In the previous section, the complementation of auxotrophy was confirmed, suggesting that mycelial fusion was carried out inside the sclerotia formed on the boundary line of strains with different auxotrophy or in the process of formation of sclerotia. . Of the sclerotia formed specifically on the borderline of the auxotrophic strains by the combination of the mating type and the combination of the SclR overexpressing strain and the control strain, uridine / uracil and adenine are not included in FIG. The mycelium that grew on the agar CD minimal medium was observed with a fluorescence microscope. As a result, in most mycelia, the color of the nucleus in one mycelium was observed with both red and green fluorescence (FIG. 15).

使用菌株、培地および形質転換Strains used, medium and transformation

[使用菌株]
大腸菌 Escherichia coli
大腸菌組換えプラスミドの取得にはE. coli DH5α(supE44 ΔlacU169(Ф80 lacZ ΔM15)hsdR17 recA1 endA1 gyrA96 thi-1 relA1) を用いた。
[Used strain]
Escherichia coli
E. coli DH5α (supE44 ΔlacU169 (Ф80 lacZ ΔM15) hsdR17 recA1 endA1 gyrA96 thi-1 relA1) was used to obtain the E. coli recombinant plasmid.

麹菌Aspergillus oryzae
本研究で使用したA. oryzae菌株一覧を表1に示した。形質転換のための親株としてはNSPlD1株(niaD- sC- adeA- ΔargB::adeA- ΔligD::argB ΔpyrG::adeA) (Maruyama and Kitamoto, 2008)を用いた。
Aspergillus oryzae
A list of A. oryzae strains used in this study is shown in Table 1. NSPlD1 strain (niaD - sC - adeA - ΔargB :: adeA - ΔligD :: argB ΔpyrG :: adeA) (Maruyama and Kitamoto, 2008) was used as a parent strain for transformation.

[使用培地]
[E. coli DH5α用]
LB培地: 1% Bacto tryptone、0.5% Yeast Extract、0.5% NaCl(プレート用寒天培地には2.0% Agarを含む。また必要に応じてkanamycinあるいはampicillinを終濃度50 mg/mlとなるように添加した。)
SOC培地: 2% Tryptone、0.5% Yeast Extract、10 mM NaCl、2.5 mM KCl、10 mM MgCl2、10 mM MgSO4、20 mM Glucose(混合後、フィルター滅菌した)
[Used medium]
[For E. coli DH5α]
LB medium : 1% Bacto tryptone, 0.5% Yeast Extract, 0.5% NaCl (The plate agar medium contains 2.0% Agar. If necessary, kanamycin or ampicillin was added to a final concentration of 50 mg / ml. .)
SOC medium : 2% Tryptone, 0.5% Yeast Extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl 2 , 10 mM MgSO 4 , 20 mM Glucose (mixed and then filter sterilized)

[A. oryzae用]
各株の栄養要求性にあわせて以下のものをそれぞれの培地に添加した。
ウリジン/ウラシル要求性;0.5% uridine + 0.2% uracil
アデニン要求性;0.01% adenyl sulfate
DPY培地:2% Dextrin、1% Polypeptone、0.5% Yeast Extract、0.5% KH2PO4、0.05% MgSO4・7H2O(pH 5.5)
CD培地:0.3% NaNO3、0.2% KCl、0.1% KH2PO4、0.05% MgSO4・7H2O、0.002% FeSO4・7H2O、2% Glucose or Maltose(pH 5.5)
M培地:0.2% NH4Cl、0.1% (NH4)2SO4、0.05% KCl、0.05% NaCl、0.1% KH2PO4、0.05% MgSO4・7H2O、0.002% FeSO4・7H2O、2% Glucose(pH 5.5)
M + Met培地:0.2% NH4Cl、0.1% (NH4)2SO4、0.05% KCl、0.05% NaCl、0.1% KH2PO4、0.05% MgSO4・7H2O、0.002% FeSO4・7H2O、2% Glucose、0.15% methionie(pH 5.5)
PD培地:日水製薬社の『真菌用 ポテトデキストロース寒天培地 「ニッスイ」』を使用法に従って作製した(組成:39.0 g中、ポテト浸出液末4.0 g・Glucose 20.0 g・Agar 15.0 g)。
MCA培地
5% Gerber mixed grain cereal (Gerber Products Co., Freemont, Michigan)、2.0% Agar
MEA培地
8.0% Malt Extract (オリエンタル酵母工業(株) バイオ事業部の微生物用培地、培地用 マルツエキス)、2.0% Agar、0.002% CuSO4、0.00004% Na2B4O7・10H2O、0.00087% FePO4、0.00095% MnSO4、0.0008% Na2MoO4、0.008% ZnSO4 (pH 6.0)
[For A. oryzae]
The following were added to each medium according to the auxotrophy of each strain.
Uridine / uracil requirement; 0.5% uridine + 0.2% uracil
Adenine requirement; 0.01% adenyl sulfate
DPY medium : 2% Dextrin, 1% Polypeptone, 0.5% Yeast Extract, 0.5% KH 2 PO 4 , 0.05% MgSO 4 .7H 2 O (pH 5.5)
CD medium : 0.3% NaNO 3 , 0.2% KCl, 0.1% KH 2 PO 4 , 0.05% MgSO4 · 7H2O, 0.002% FeSO4 · 7H 2 O, 2% Glucose or Maltose (pH 5.5)
M medium : 0.2% NH 4 Cl, 0.1% (NH 4 ) 2 SO 4 , 0.05% KCl, 0.05% NaCl, 0.1% KH 2 PO 4 , 0.05% MgSO 4 .7H 2 O, 0.002% FeSO 4 .7H 2 O, 2% Glucose (pH 5.5)
M + Met medium : 0.2% NH 4 Cl, 0.1% (NH 4 ) 2 SO 4 , 0.05% KCl, 0.05% NaCl, 0.1% KH 2 PO 4 , 0.05% MgSO 4 .7H 2 O, 0.002% FeSO 4. 7H 2 O, 2% Glucose, 0.15% methionie (pH 5.5)
PD medium : “Nissui”, a potato dextrose agar medium for fungi, manufactured by Nissui Pharmaceutical Co., Ltd. was prepared according to the usage method (composition: 39.0 g, potato leachate powder 4.0 g · Glucose 20.0 g · Agar 15.0 g).
MCA medium
5% Gerber mixed grain cereal (Gerber Products Co., Freemont, Michigan), 2.0% Agar
MEA medium
8.0% Malt Extract (Oriental Yeast Industry Co., Ltd. Bio Division Microorganism Medium, Medium Malt Extract), 2.0% Agar, 0.002% CuSO 4 , 0.00004% Na 2 B 4 O 7 / 10H 2 O, 0.00087% FePO 4 , 0.00095% MnSO 4 , 0.0008% Na 2 MoO 4 , 0.008% ZnSO 4 (pH 6.0)

[遺伝子操作]
[プラスミドの作製]
本研究で使用したプライマーは表2、プラスミドは表3に示した。これらのプラスミドのうち、pgHHDRS、pgHHGS、pgABpGはMultiSite Gateway(商標)cloning system を用いて作製した。
[Gene manipulation]
[Plasmid preparation]
The primers used in this study are shown in Table 2, and the plasmids are shown in Table 3. Of these plasmids, pgHHDRS, pgHHGS, and pgABpG were prepared using the MultiSite Gateway ™ cloning system.

pgHHDRS
核を赤色蛍光で標識するためのプラスミドpgHHDRSは、5' entry clone (pg5'PH)、center entry clone (pgH2B) 、3' entry clone (pg3'DRM-CF)と形質転換用選択マーカーとしてAosCマーカーを含むdestination vector (pgDSO)を混合してLR反応を行い、作製した。
pgHHGS
核を緑色蛍光で標識するためのプラスミドはpgHHGSは、5' entry clone (pg5'PH)、center entry clone (pgH2B) 、3' entry clone (pg3'E)と形質転換用選択マーカーとしてAosCマーカーを含むdestination vector (pgDSO)を混合してLR反応を行い、作製した。
pgHHDRS
Plasmid pgHHDRS for labeling nuclei with red fluorescence is 5 'entry clone (pg5'PH), center entry clone (pgH2B), 3' entry clone (pg3'DRM-CF) and AosC marker as a selection marker for transformation Destination vector (pgDSO) containing LR was mixed and prepared.
pgHHGS
Plasmids for labeling nuclei with green fluorescence are pgHHGS, 5 'entry clone (pg5'PH), center entry clone (pgH2B), 3' entry clone (pg3'E) and AosC marker as a selection marker for transformation. A destination vector (pgDSO) containing the mixture was mixed to prepare an LR reaction.

pgABpG
adeB遺伝子上流1.0 kbをプライマーattB4-5aB-FとattB1-5aB-Rで、adeB遺伝子下流1.0 kbをプライマーattB2-3aB-FとattB3-3aB-Rでそれぞれ増幅し、adeB遺伝子上流のDNA断片の増幅産物を5' entry vector (pDONR P4-P1R)にBP反応により挿入することで5' entry clone (pg5’AB4)、adeB遺伝子下流のDNA断片の増幅産物を3' entry vector (pDONR P2R-P3)にBP反応により挿入することで3' entry clone (pg3’AB4)を作製した。さらに5' entry clone (pg5'AB4)、3' entry clone (pg3'AB4)、center entry clone (pgEpG)とdestination vector (pDEST R4-R3)を混合してLR反応を行った。以上によってadeB遺伝子破壊用プラスミドpgABpGを作製した。pgABpGを鋳型とし、プライマーattB4-5aB-FとattB3-3aB-Rを用いてPCRでadeB遺伝子破壊のための遺伝子断片を増幅した。
pgABpG
AdeB gene upstream 1.0 kb is amplified with primers attB4-5aB-F and attB1-5aB-R, and adeB gene downstream 1.0 kb is amplified with primers attB2-3aB-F and attB3-3aB-R. By inserting the amplified product into the 5 'entry vector (pDONR P4-P1R) by BP reaction, the 5' entry clone (pg5'AB4) and the amplified product of the DNA fragment downstream of the adeB gene are converted into the 3 'entry vector (pDONR P2R-P3 3 'entry clone (pg3'AB4) was prepared by inserting into) by BP reaction. Furthermore, 5 'entry clone (pg5'AB4), 3' entry clone (pg3'AB4), center entry clone (pgEpG) and destination vector (pDEST R4-R3) were mixed to perform LR reaction. Thus, the plasmid pgABpG for adeB gene disruption was prepared. A gene fragment for adeB gene disruption was amplified by PCR using pgABpG as a template and primers attB4-5aB-F and attB3-3aB-R.

[PCR条件]
各遺伝子のクローニングには、ポリメラーゼとしてPrimeSTAR (TaKaRa)を用いた。テンプレートとしてA. oryzae RIB40株の染色体DNAを用いた。また、A. oryzaeのコロニーPCRにはKOD FX Neo (TOYOBO)を用いた。反応液の組成は全て添付の説明書に従った。
[PCR conditions]
For cloning of each gene, PrimeSTAR (TaKaRa) was used as a polymerase. Chromosomal DNA of A. oryzae RIB40 strain was used as a template. In addition, KOD FX Neo (TOYOBO) was used for colony PCR of A. oryzae. The composition of the reaction solution was in accordance with the attached instructions.

Prime STAR温度条件
98℃ 2 min、{98℃ 10 sec、(アニーリング温度)15 sec、72℃ 1 kb/min;30 cycle}、4℃
KOD FX Neo温度条件
94℃ 5 min、{98℃ 10 sec、(アニーリング温度)30 sec、68℃ 2 kb/min;45 cycle}、4℃
テンプレートには、20 μlスケールあたり50 μl TEに白金耳懸濁した溶液2 μlを用いた。
Prime STAR temperature conditions
98 ℃ 2 min, {98 ℃ 10 sec, (annealing temperature) 15 sec, 72 ℃ 1 kb / min; 30 cycle}, 4 ℃
KOD FX Neo temperature conditions
94 ℃ 5 min, {98 ℃ 10 sec, (annealing temperature) 30 sec, 68 ℃ 2 kb / min; 45 cycle}, 4 ℃
As a template, 2 μl of a platinum loop suspension in 50 μl TE per 20 μl scale was used.

[プラスミドDNAの調製]
大腸菌プラスミドDNAの調製は、アルカリSDS法もしくはPromega社のキット (Cat. No. A1222) を用いて行った。
[Preparation of plasmid DNA]
E. coli plasmid DNA was prepared using an alkaline SDS method or a kit from Promega (Cat. No. A1222).

[DNAシークエンス]
ファスマック社による受注シークエンスを行った。
[DNA sequence]
An order sequence was made by Fasmac.

[大腸菌の形質転換]
MultiSite Gateway(商標)systemを用いた場合の形質転換は、以下の方法を用いた。その他の形質転換についてはHanahanの方法 (Hanahan, 1983)に従った。
[Transformation of E. coli]
The following method was used for transformation using the MultiSite Gateway (trademark) system. For other transformations, the method of Hanahan (Hanahan, 1983) was followed.

MultiSite Gatewayシステムで作製するプラスミド取得のための形質転換
100 μlのコンピテントセルに5 μlの酵素反応 (BP反応およびLR反応)液を加えて混合し、氷上で30分間放置後、42℃で1分間インキュベートして素早く氷上へ移す。
SOC培地250 μlを加えて37℃で1時間振盪培養した後、LB 選択培地 (LB + kanamycinあるいはampicillin)に塗布。37℃、一晩の培養によりコロニーを得る。
Transformation for obtaining plasmids produced with the MultiSite Gateway system
Add 5 μl of enzyme reaction solution (BP reaction and LR reaction) to a 100 μl competent cell, mix, leave on ice for 30 minutes, incubate at 42 ° C for 1 minute, and quickly transfer to ice.
Add 250 μl of SOC medium and incubate at 37 ° C for 1 hour with shaking, then apply to LB selective medium (LB + kanamycin or ampicillin). Colonies are obtained by overnight culture at 37 ° C.

[A. oryzae形質転換法]
プロトプラストPEG法
親株を100 mlのDPY液体培地を用いて30℃で18〜20時間振盪培養し、ミラクロス (CALBIOCHEM)を用いて菌体を回収する。
回収した菌体を滅菌水で洗浄後、10 ml TF Solution 1 (1% Yatalase (TaKaRa), 0.6 M (NH4)2SO4, 50mM Maleate buffer (pH 5.5))により30℃で3時間処理してプロトプラスト化する。
ミラクロスを用いてプロトプラストを回収して10 ml TF Solution 2 (1.2 M Sorbitol, 50 mM CaCl2, 35 mM NaCl, 10 mM Tris-HCl (pH 7.5))を加え、遠心して沈殿を回収する。同様の操作でプロトプラストをさらに2回洗い、1.0-5.0×107個/ mlとなるようにTF Solution 2 に懸濁する。
200 μlのプロトプラスト懸濁液に1-5 μg/10μlの形質転換用DNAを10μl加えて、氷中に30分間静置する。
250、250、850 μlと3回に分けてTF Solution 3 (60% PEG4000, 50 mM CaCl2, 10 mM Tris-HCl (pH 7.5))を加え、室温で20分間静置する。
5 mlのTF Solution 2を加えて遠心後、ペレットを500μlのTF Solution 2 に再懸濁し、懸濁液をあらかじめ45℃で保温しておいたTop agar (1.2 M Sorbitol, 0.8% Agar入り選択培地)と混和して下層培地 (1.2 M Sorbitol, 1.5% Agar入り選択培地)に重層する。30℃で3-7日間培養して形質転換体を取得し、選択培地で1〜3回程度植え継ぐことにより、形質を安定させる。
[A. oryzae transformation method]
Protoplast PEG method The parent strain is cultured with shaking in 100 ml of DPY liquid medium at 30C for 18 to 20 hours, and the cells are collected using Miracloth (CALBIOCHEM).
The collected cells are washed with sterilized water and treated with 10 ml TF Solution 1 (1% Yatalase (TaKaRa), 0.6 M (NH 4 ) 2 SO 4 , 50 mM Maleate buffer (pH 5.5)) at 30 ° C for 3 hours. To protoplast.
Protoplasts are collected using Miracloth, 10 ml TF Solution 2 (1.2 M Sorbitol, 50 mM CaCl 2 , 35 mM NaCl, 10 mM Tris-HCl (pH 7.5)) is added, and the precipitate is collected by centrifugation. In the same way, wash the protoplasts twice more and suspend in TF Solution 2 to 1.0-5.0 × 10 7 cells / ml.
Add 10 μl of 1-5 μg / 10 μl of DNA for transformation to 200 μl of protoplast suspension, and leave on ice for 30 minutes.
Add TF Solution 3 (60% PEG4000, 50 mM CaCl 2 , 10 mM Tris-HCl (pH 7.5)) in three portions of 250, 250, and 850 μl, and let stand at room temperature for 20 minutes.
After adding 5 ml of TF Solution 2 and centrifuging, the pellet was resuspended in 500 μl of TF Solution 2, and the suspension was pre-warmed at 45 ° C. Top agar (1.2 M Sorbitol, 0.8% Agar-containing selective medium) ) And layer on the lower layer medium (selective medium containing 1.2 M Sorbitol, 1.5% Agar). The transformant is obtained by culturing at 30 ° C. for 3-7 days, and the trait is stabilized by inoculating it about 1 to 3 times with a selective medium.

[サザンブロッティング解析]
回収した形質転換体の染色体DNA 25 μgを一晩で制限酵素処理した後、0.8%アガロースゲルで電気泳動を行った。その後の操作は、ECL direct nucleic acid labeling and detection systems (Healthcare Bioscience)及びPositively charged Nylon transfer membrane Hybond-N+ (Healthcare Bioscience)を用いて、説明書に従って行った。また、バンドの検出には、ルミノイメージアナライザーLAS-1000plus (Fujiflim)を用いた。トランスファーは一晩、メンブレンの乾熱固定は100℃で 2時間、プレハイブリダイゼーション1時間そしてハイブリダイゼーション 8時間もしくは一晩で行った。
[Southern blotting analysis]
25 μg of the chromosomal DNA of the collected transformant was treated with a restriction enzyme overnight, and then electrophoresed on a 0.8% agarose gel. Subsequent operations were performed according to the instructions using ECL direct nucleic acid labeling and detection systems (Healthcare Bioscience) and Positively charged Nylon transfer membrane Hybond-N + (Healthcare Bioscience). For detection of the band, a lumino image analyzer LAS-1000plus (Fujiflim) was used. Transfer was carried out overnight, and dry heat fixation of the membrane was carried out at 100 ° C. for 2 hours, prehybridization 1 hour and hybridization 8 hours or overnight.

[菌糸融合実験]
寒天培地での対峙培養
MEA培地上に4 cmの間隔で異なる接合型株の分生子を103 個/5 μlずつ植菌した。10日から14日25℃・暗所・通気条件で培養した後、異なる栄養要求性を持つ株の境界線上に形成された菌核を、ウリジン/ウラシル・アデニンを含まないCD最少培地に滅菌したピンセットで菌核をシフトし、その後の生育を見た。シフト後、約3-5日30℃で培養して菌糸成長を示した株の菌糸を、蛍光顕微鏡を用いて核の色を赤・緑色の波長で観察した。
[Mycelium fusion experiment]
Confrontation culture on agar medium
10 3 pieces / 5 μl of conidia of different mating type strains were inoculated on the MEA medium at intervals of 4 cm. After culturing at 25 ° C, dark place, and aeration conditions for 10 to 14 days, sclerotia formed on the boundary line of strains with different auxotrophy is sterilized in CD minimal medium without uridine / uracil adenine The mycorrhiza was shifted with tweezers and the subsequent growth was observed. After the shift, the mycelium of the strain that had been cultured at 30 ° C. for about 3-5 days and showed mycelia growth was observed for the color of the nucleus at red and green wavelengths using a fluorescence microscope.

[顕微鏡観察法]
[使用機器]
共焦点レーザー顕微鏡によるEGFP蛍光、mDsRed蛍光の観察においては、対物レンズNeofluor 40x、100x (Olympus)と共焦点スキャナシステムCSU22 (Yokogawa)を装備したIX71N倒立型顕微鏡 (Olympus)を用いた。解析ソフトウェアはAndor iQ (Andor Technology PLC)を使用した。また、蛍光像を取得する際にはAndor iXon cooled digital charge-coupled-device camera (Andor Technology PLC)を用いた。
[培養方法]
ガラスベースディッシュ (IWAKI Glass-base dish)をUV照射により15分以上滅菌した後、培地100 μlを滴下し、分生子あるいは菌糸を植菌した。その後、パラフィルムでガラスベースディッシュを密閉し、静置培養を行った。
[Microscopic observation method]
[Used equipment]
In the observation of EGFP fluorescence and mDsRed fluorescence with a confocal laser microscope, an IX71N inverted microscope (Olympus) equipped with an objective lens Neofluor 40x, 100x (Olympus) and a confocal scanner system CSU22 (Yokogawa) was used. The analysis software was Andor iQ (Andor Technology PLC). In addition, an Andor iXon cooled digital charge-coupled-device camera (Andor Technology PLC) was used to acquire a fluorescent image.
[Culture method]
A glass base dish (IWAKI Glass-base dish) was sterilized by UV irradiation for 15 minutes or more, and then 100 μl of the medium was dropped to inoculate conidia or mycelium. Thereafter, the glass base dish was sealed with parafilm, and stationary culture was performed.

アスペルギルス属細胞株の中で、アスペルギルス・オリゼのような不完全菌として分類される菌株に関して、有性生殖が確認された場合には、本発明方法を利用することによって、細胞株の融合効率を高めたり、融合の確認を容易にすることが可能となる。従って、本発明は、アスペルギルス・オリゼのようなアスペルギルス属細胞において、複数の株の優良な表現型を備えた株の育種を効率的に行う技術の開発に大いに資するものである。 When sexual reproduction is confirmed for a strain classified as an incomplete bacterium, such as Aspergillus oryzae, among the Aspergillus genus cell lines, the fusion efficiency of the cell line can be increased by using the method of the present invention. It becomes possible to increase or facilitate confirmation of fusion. Therefore, the present invention greatly contributes to the development of a technique for efficiently breeding a strain having excellent phenotypes of a plurality of strains in Aspergillus oryzae cells such as Aspergillus oryzae.

[参考文献]
Agnihotri VP (1968) Effects of nitrogenous compounds on sclerotium formation in Aspergillus niger. Can J Microbiol 14: 1253-1258
Amselem J, Cuomo CA, van Kan JA, Viaud M, Benito EP, Couloux A, Coutinho PM, de Vries RP, Dyer PS, Fillinger S, Fournier E, Gout L, Hahn M, Kohn L, Lapalu N, Plummer KM, Pradier JM, Quevillon E, Sharon A, Simon A et al (2011) Genomic analysis of the necrotrophic fungal pathogens Sclerotinia sclerotiorum and Botrytis cinerea. PLoS Genet 7: e1002230
Barbesgaard P, Heldt-Hansen HP, & Diderichsen B (1992) On the safety of Aspergillus oryzae: a review. Appl Microbiol Biotechnol 36: 569-572
Bolton MD, Thomma BP, & Nelson BD (2006) Sclerotinia sclerotiorum (Lib.) de Bary: biology and molecular traits of a cosmopolitan pathogen. Mol Plant Pathol 7: 1-16
Braumann I, van den Berg M, & Kempken F (2008) Repeat induced point mutation in two asexual fungi, Aspergillus niger and Penicillium chrysogenum. Curr Genet 53: 287-297
Brown SH, Scott JB, Bhaheetharan J, Sharpee WC, Milde L, Wilson RA, & Keller NP (2009) Oxygenase coordination is required for morphological transition and the host-fungus interaction of Aspergillus flavus. Mol Plant Microbe Interact 22: 882-894
Brown SH, Zarnowski R, Sharpee WC, & Keller NP (2008) Morphological transitions governed by density dependence and lipoxygenase activity in Aspergillus flavus. Appl Environ Microbiol 74: 5674-5685
Chang PK &Ehrlich KC (2010) What does genetic diversity of Aspergillus flavus tell us about Aspergillus oryzae? Int J Food Microbiol 138: 189-199
Dyer PS (2007) Sexual Reproduction and Significance of MAT in the Aspergilli. In Sex in Fungi: Molecular Determination and Evolutionary Principles, Heitman J, Kronstad JW, Taylor JW, Casselton LA (eds) pp 123-142. American Society for Microbiology: Washington, DC.
Dyer PS &O'Gorman CM (2012) Sexual development and cryptic sexuality in fungi: insights from Aspergillus species. FEMS Microbiol Rev 36: 165-192
Erentala A, Dickmanb MB, & Yarden O (2008) Sclerotial development in Sclerotinia sclerotiorum: awakening molecular analysis of a “Dormant” structure Fungal Biol Rev 22: 6-16
Escano CS, Juvvadi PR, Jin FJ, Takahashi T, Koyama Y, Yamashita S, Maruyama J, & Kitamoto K (2009) Disruption of the Aopex11-1 gene involved in peroxisome proliferation leads to impaired Woronin body formation in Aspergillus oryzae. Eukaryot Cell 8: 296-305
Galagan JE, Calvo SE, Cuomo C, Ma LJ, Wortman JR, Batzoglou S, Lee SI, Basturkmen M, Spevak CC, Clutterbuck J, Kapitonov V, Jurka J, Scazzocchio C, Farman M, Butler J, Purcell S, Harris S, Braus GH, Draht O, Busch S et al (2005) Sequencing of Aspergillus nidulans and comparative analysis with A. fumigatus and A. oryzae. Nature 438: 1105-1115
Geiser DM (2009) Sexual structures in Aspergillus: morphology, importance and genomics. Med Mycol 47 Suppl 1: S21-6
Gomi K, Iimura Y, & Hara S (1987) Integrative transformation of Aspergillus oryzae with a plasmid containing the Aspergillus nidulans argB gene. Agric Biol Chem 51: 2549-2555
Horn BW, Moore GG, & Carbone I (2009a) Sexual reproduction in Aspergillus flavus. Mycologia 101: 423-429
Horn BW, Ramirez-Prado JH, & Carbone I (2009b) The sexual state of Aspergillus parasiticus. Mycologia 101: 275-280
Ito K, Asakura T, Morita Y, Nakajima K, Koizumi A, Shimizu-Ibuka A, Masuda K, Ishiguro M, Terada T, Maruyama J, Kitamoto K, Misaka T, & Abe K (2007) Microbial production of sensory-active miraculin. Biochem Biophys Res Commun 360: 407-411
Jin FJ, Maruyama J, Juvvadi PR, Arioka M, & Kitamoto K (2004a) Adenine auxotrophic mutants of Aspergillus oryzae: development of a novel transformation system with triple auxotrophic hosts. Biosci Biotechnol Biochem 68: 656-662
Jin FJ, Maruyama J, Juvvadi PR, Arioka M, & Kitamoto K (2004b) Development of a novel quadruple auxotrophic host transformation system by argB gene disruption using adeA gene and exploiting adenine auxotrophy in Aspergillus oryzae. FEMS Microbiol Lett 239: 79-85
Jin FJ, Takahashi T, Machida M, & Koyama Y (2009) Identification of a basic helix-loop-helix-type transcription regulator gene in Aspergillus oryzae by systematically deleting large chromosomal segments. Appl Environ Microbiol 75: 5943-5951
Jin FJ, Takahashi T, Matsushima K, Hara S, Shinohara Y, Maruyama J, Kitamoto K, &Koyama Y (2011) SclR, a basic helix-loop-helix transcription factor, regulates hyphal morphology and promotes sclerotial formation in Aspergillus oryzae. Eukaryot Cell 10: 945-955
Kitamoto K (2002) Molecular biology of the Koji molds. Adv Appl Microbiol 51: 129-153
Kubodera T, Yamashita N, & Nishimura A (2000) Pyrithiamine resistance gene (ptrA) of Aspergillus oryzae: cloning, characterization and application as a dominant selectable marker for transformation. Biosci Biotechnol Biochem 64: 1416-1421
Machida M, Asai K, Sano M, Tanaka T, Kumagai T, Terai G, Kusumoto K, Arima T, Akita O, Kashiwagi Y, Abe K, Gomi K, Horiuchi H, Kitamoto K, Kobayashi T, Takeuchi M, Denning DW, Galagan JE, Nierman WC, Yu J et al (2005) Genome sequencing and analysis of Aspergillus oryzae. Nature 438: 1157-1161
Maruyama J & Kitamoto K (2008) Multiple gene disruptions by marker recycling with highly efficient gene-targeting background (DeltaligD) in Aspergillus oryzae. Biotechnol Lett 30: 1811-1817
Mattern IE, Unkles S, Kinghorn JR, Pouwels PH, & van den Hondel CA (1987) Transformation of Aspergillus oryzae using the A. niger pyrG gene. Mol Gen Genet 210: 460-461
McAlpin CE & Wicklow DT (2005) Culture media and sources of nitrogen promoting the formation of stromata and ascocarps in Petromyces alliaceus (Aspergillus section Flavi). Can J Microbiol 51: 765-771
Mizutani O, Kudo Y, Saito A, Matsuura T, Inoue H, Abe K, & Gomi K (2008) A defect of LigD (human Lig4 homolog) for nonhomologous end joining significantly improves efficiency of gene-targeting in Aspergillus oryzae. Fungal Genet Biol 45: 878-889
Montiel MD, Lee HA, & Archer DB (2006) Evidence of RIP (repeat-induced point mutation) in transposase sequences of Aspergillus oryzae. Fungal Genet Biol 43: 439-445
Murakami H (1971) Classification of the Koji Mold J Gen Appl Microbiol 17: 281-309
Nakajima K, Asakura T, Maruyama J, Morita Y, Oike H, Shimizu-Ibuka A, Misaka T, Sorimachi H, Arai S, Kitamoto K, & Abe K (2006) Extracellular production of neoculin, a sweet-tasting heterodimeric protein with taste-modifying activity, by Aspergillus oryzae. Appl Environ Microbiol 72: 3716-3723
O'Gorman CM, Fuller HT, & Dyer PS (2009) Discovery of a sexual cycle in the opportunistic fungal pathogen Aspergillus fumigatus. Nature 457: 471-474
Samson RA & Varga J (2010) Molecular systematics of Aspergillus and its teleomorphs. In Aspergillus Molecular Biology and Genomics Machida M & Gomi K (eds) pp 19-40. Caister Academic Press: Norfork
Takahashi T, Masuda T, & Koyama Y (2006) Enhanced gene targeting frequency in ku70 and ku80 disruption mutants of Aspergillus sojae and Aspergillus oryzae. Mol Genet Genomics 275: 460-470
Tsuchiya K, Nagashima T, Yamamoto Y, Gomi K, Kitamoto K, Kumagai C, & Tamura G (1994) High level secretion of calf chymosin using a glucoamylase-prochymosin fusion gene in Aspergillus oryzae. Biosci Biotechnol Biochem 58: 895-899
Tsuchiya K, Tada S, Gomi K, Kitamoto K, Kumagai C, Jigami Y, & Tamura G (1992) High level expression of the synthetic human lysozyme gene in Aspergillus oryzae. Appl Microbiol Biotechnol 38: 109-114
Wada R, Maruyama J, Yamaguchi H, Yamamoto N, Wagu Y, Paoletti M, Archer DB, Dyer PS, & Kitamoto K (2012) Presence and Functionality of Mating-Type Genes in the Supposedly Asexual Filamentous Fungus Aspergillus oryzae. Appl Environ Microbiol in press
Willetts HJ & Bullock S (1992) Developmental biology of sclerotia. Mycol Res 96: 801-816
Yamada O, Lee BR, & Gomi K (1997) Transformation system for Aspergillus oryzae with double auxotrophic mutations, niaD and sC. Biosci Biotechnol Biochem 61: 1367-1368
Yamada O, Lee BR, Gomi K, & Iimura Y (1999) Cloning and functional analysis of the Aspergillus oryzae conidiation regulator gene brlA by its disruption and misscheduled expression. J Biosci Bioeng 87: 424-429
Yoon J, Kimura S, Maruyama J, & Kitamoto K (2009) Construction of quintuple protease gene disruptant for heterologous protein production in Aspergillus oryzae. Appl Microbiol Biotechnol 82: 691-701
Yoon J, Maruyama J, & Kitamoto K (2011) Disruption of ten protease genes in the filamentous fungus Aspergillus oryzae highly improves production of heterologous proteins. Appl Microbiol Biotechnol 89: 747-759
一島英治 (2003) 分子麹菌学
[References]
Agnihotri VP (1968) Effects of nitrogenous compounds on sclerotium formation in Aspergillus niger. Can J Microbiol 14: 1253-1258
Amselem J, Cuomo CA, van Kan JA, Viaud M, Benito EP, Couloux A, Coutinho PM, de Vries RP, Dyer PS, Fillinger S, Fournier E, Gout L, Hahn M, Kohn L, Lapalu N, Plummer KM, Pradier JM, Quevillon E, Sharon A, Simon A et al (2011) Genomic analysis of the necrotrophic fungal pathogens Sclerotinia sclerotiorum and Botrytis cinerea.PLoS Genet 7: e1002230
Barbesgaard P, Heldt-Hansen HP, & Diderichsen B (1992) On the safety of Aspergillus oryzae: a review.Appl Microbiol Biotechnol 36: 569-572
Bolton MD, Thomma BP, & Nelson BD (2006) Sclerotinia sclerotiorum (Lib.) De Bary: biology and molecular traits of a cosmopolitan pathogen. Mol Plant Pathol 7: 1-16
Braumann I, van den Berg M, & Kempken F (2008) Repeat induced point mutation in two asexual fungi, Aspergillus niger and Penicillium chrysogenum. Curr Genet 53: 287-297
Brown SH, Scott JB, Bhaheetharan J, Sharpee WC, Milde L, Wilson RA, & Keller NP (2009) Oxygenase coordination is required for morphological transition and the host-fungus interaction of Aspergillus flavus. Mol Plant Microbe Interact 22: 882-894
Brown SH, Zarnowski R, Sharpee WC, & Keller NP (2008) Morphological transitions governed by density dependence and lipoxygenase activity in Aspergillus flavus.Appl Environ Microbiol 74: 5674-5685
Chang PK & Ehrlich KC (2010) What does genetic diversity of Aspergillus flavus tell us about Aspergillus oryzae? Int J Food Microbiol 138: 189-199
Dyer PS (2007) Sexual Reproduction and Significance of MAT in the Aspergilli.In Sex in Fungi: Molecular Determination and Evolutionary Principles, Heitman J, Kronstad JW, Taylor JW, Casselton LA (eds) pp 123-142. American Society for Microbiology: Washington, DC.
Dyer PS &O'Gorman CM (2012) Sexual development and cryptic sexuality in fungi: insights from Aspergillus species.FEMS Microbiol Rev 36: 165-192
Erentala A, Dickmanb MB, & Yarden O (2008) Sclerotial development in Sclerotinia sclerotiorum: awakening molecular analysis of a “Dormant” structure Fungal Biol Rev 22: 6-16
Escano CS, Juvvadi PR, Jin FJ, Takahashi T, Koyama Y, Yamashita S, Maruyama J, & Kitamoto K (2009) Disruption of the Aopex11-1 gene involved in peroxisome proliferation leads to impaired Woronin body formation in Aspergillus oryzae.Eukaryot Cell 8: 296-305
Galagan JE, Calvo SE, Cuomo C, Ma LJ, Wortman JR, Batzoglou S, Lee SI, Basturkmen M, Spevak CC, Clutterbuck J, Kapitonov V, Jurka J, Scazzocchio C, Farman M, Butler J, Purcell S, Harris S , Braus GH, Draht O, Busch S et al (2005) Sequencing of Aspergillus nidulans and comparative analysis with A. fumigatus and A. oryzae. Nature 438: 1105-1115
Geiser DM (2009) Sexual structures in Aspergillus: morphology, importance and genomics. Med Mycol 47 Suppl 1: S21-6
Gomi K, Iimura Y, & Hara S (1987) Integrative transformation of Aspergillus oryzae with a plasmid containing the Aspergillus nidulans argB gene.Agric Biol Chem 51: 2549-2555
Horn BW, Moore GG, & Carbone I (2009a) Sexual reproduction in Aspergillus flavus.Mycologia 101: 423-429
Horn BW, Ramirez-Prado JH, & Carbone I (2009b) The sexual state of Aspergillus parasiticus.Mycologia 101: 275-280
Ito K, Asakura T, Morita Y, Nakajima K, Koizumi A, Shimizu-Ibuka A, Masuda K, Ishiguro M, Terada T, Maruyama J, Kitamoto K, Misaka T, & Abe K (2007) Microbial production of sensory-active miraculin. Biochem Biophys Res Commun 360: 407-411
Jin FJ, Maruyama J, Juvvadi PR, Arioka M, & Kitamoto K (2004a) Adenine auxotrophic mutants of Aspergillus oryzae: development of a novel transformation system with triple auxotrophic hosts.Biosci Biotechnol Biochem 68: 656-662
Jin FJ, Maruyama J, Juvvadi PR, Arioka M, & Kitamoto K (2004b) Development of a novel quadruple auxotrophic host transformation system by argB gene disruption using adeA gene and exploiting adenine auxotrophy in Aspergillus oryzae.FEMS Microbiol Lett 239: 79-85
Jin FJ, Takahashi T, Machida M, & Koyama Y (2009) Identification of a basic helix-loop-helix-type transcription regulator gene in Aspergillus oryzae by systematically deleting large chromosomal segments. Appl Environ Microbiol 75: 5943-5951
Jin FJ, Takahashi T, Matsushima K, Hara S, Shinohara Y, Maruyama J, Kitamoto K, & Koyama Y (2011) SclR, a basic helix-loop-helix transcription factor, regulates hyphal morphology and promotes sclerotial formation in Aspergillus oryzae. Cell 10: 945-955
Kitamoto K (2002) Molecular biology of the Koji molds.Adv Appl Microbiol 51: 129-153
Kubodera T, Yamashita N, & Nishimura A (2000) Pyrithiamine resistance gene (ptrA) of Aspergillus oryzae: cloning, characterization and application as a dominant selectable marker for transformation.Biosci Biotechnol Biochem 64: 1416-1421
Machida M, Asai K, Sano M, Tanaka T, Kumagai T, Terai G, Kusumoto K, Arima T, Akita O, Kashiwagi Y, Abe K, Gomi K, Horiuchi H, Kitamoto K, Kobayashi T, Takeuchi M, Denning DW , Galagan JE, Nierman WC, Yu J et al (2005) Genome sequencing and analysis of Aspergillus oryzae.Nature 438: 1157-1161
Maruyama J & Kitamoto K (2008) Multiple gene disruptions by marker recycling with highly efficient gene-targeting background (DeltaligD) in Aspergillus oryzae. Biotechnol Lett 30: 1811-1817
Mattern IE, Unkles S, Kinghorn JR, Pouwels PH, & van den Hondel CA (1987) Transformation of Aspergillus oryzae using the A. niger pyrG gene. Mol Gen Genet 210: 460-461
McAlpin CE & Wicklow DT (2005) Culture media and sources of nitrogen promoting the formation of stromata and ascocarps in Petromyces alliaceus (Aspergillus section Flavi). Can J Microbiol 51: 765-771
Mizutani O, Kudo Y, Saito A, Matsuura T, Inoue H, Abe K, & Gomi K (2008) A defect of LigD (human Lig4 homolog) for nonhomologous end joining significantly improves efficiency of gene-targeting in Aspergillus oryzae. Biol 45: 878-889
Montiel MD, Lee HA, & Archer DB (2006) Evidence of RIP (repeat-induced point mutation) in transposase sequences of Aspergillus oryzae. Fungal Genet Biol 43: 439-445
Murakami H (1971) Classification of the Koji Mold J Gen Appl Microbiol 17: 281-309
Nakajima K, Asakura T, Maruyama J, Morita Y, Oike H, Shimizu-Ibuka A, Misaka T, Sorimachi H, Arai S, Kitamoto K, & Abe K (2006) Extracellular production of neoculin, a sweet-tasting heterodimeric protein with taste-modifying activity, by Aspergillus oryzae.Appl Environ Microbiol 72: 3716-3723
O'Gorman CM, Fuller HT, & Dyer PS (2009) Discovery of a sexual cycle in the opportunistic fungal pathogen Aspergillus fumigatus.Nature 457: 471-474
Samson RA & Varga J (2010) Molecular systematics of Aspergillus and its teleomorphs. In Aspergillus Molecular Biology and Genomics Machida M & Gomi K (eds) pp 19-40.Caister Academic Press: Norfork
Takahashi T, Masuda T, & Koyama Y (2006) Enhanced gene targeting frequency in ku70 and ku80 disruption mutants of Aspergillus sojae and Aspergillus oryzae. Mol Genet Genomics 275: 460-470
Tsuchiya K, Nagashima T, Yamamoto Y, Gomi K, Kitamoto K, Kumagai C, & Tamura G (1994) High level secretion of calf chymosin using a glucoamylase-prochymosin fusion gene in Aspergillus oryzae. Biosci Biotechnol Biochem 58: 895-899
Tsuchiya K, Tada S, Gomi K, Kitamoto K, Kumagai C, Jigami Y, & Tamura G (1992) High level expression of the synthetic human lysozyme gene in Aspergillus oryzae.Appl Microbiol Biotechnol 38: 109-114
Wada R, Maruyama J, Yamaguchi H, Yamamoto N, Wagu Y, Paoletti M, Archer DB, Dyer PS, & Kitamoto K (2012) Presence and Functionality of Mating-Type Genes in the Supposedly Asexual Filamentous Fungus Aspergillus oryzae.Appl Environ Microbiol in press
Willetts HJ & Bullock S (1992) Developmental biology of sclerotia.Mycol Res 96: 801-816
Yamada O, Lee BR, & Gomi K (1997) Transformation system for Aspergillus oryzae with double auxotrophic mutations, niaD and sC. Biosci Biotechnol Biochem 61: 1367-1368
Yamada O, Lee BR, Gomi K, & Iimura Y (1999) Cloning and functional analysis of the Aspergillus oryzae conidiation regulator gene brlA by its disruption and misscheduled expression.J Biosci Bioeng 87: 424-429
Yoon J, Kimura S, Maruyama J, & Kitamoto K (2009) Construction of quintuple protease gene disruptant for heterologous protein production in Aspergillus oryzae.Appl Microbiol Biotechnol 82: 691-701
Yoon J, Maruyama J, & Kitamoto K (2011) Disruption of ten protease genes in the filamentous fungus Aspergillus oryzae highly improves production of heterologous proteins.Appl Microbiol Biotechnol 89: 747-759
Eiji Ichijima (2003) Molecular bacteriology

Claims (9)

2種類のアスペルギルス・オリゼ細胞株(菌糸)を対峙培養し、境界線上に特異的に形成される菌核内又は該菌核の形成過程における該2種類のアスペルギルス・オリゼ細胞株の融合によって、同一細胞内に異なる細胞株由来の核が存在する異核共存体(ヘテロカリオン)である融合菌糸を作製する方法であって、
該2種類のアスペルギルス・オリゼ細胞株が夫々別の表現型により互いに識別可能な形質転換体であり、且つ、該2種類のアスペルギルス・オリゼ細胞株の少なくとも一方において菌核形成促進因子SclRの発現を増加させることにより、該2種類のアスペルギルス・オリゼ細胞株の融合効率を増加させることを特徴とする、前記方法。
Two types of Aspergillus oryzae cell lines (mycelia) are cultured oppositely, and are the same by fusion of the two types of Aspergillus oryzae cell lines in the nuclei specifically formed on the boundary line or in the formation process of the sclerotia A method for producing a fusion mycelium that is a heteronuclear coexistence body (heterokaryon) in which nuclei from different cell lines are present in cells,
The two types of Aspergillus oryzae cell lines are transformants that can be distinguished from each other by different phenotypes, and at least one of the two types of Aspergillus oryzae cell lines expresses the nucleation promoting factor SclR. Said method, characterized by increasing the fusion efficiency of said two types of Aspergillus oryzae cell lines by increasing.
プロモーター制御下に連結された以下の(a)、(b)、(c)、(d)又は(e)のDNA:The following DNA (a), (b), (c), (d) or (e) linked under the control of a promoter:
(a)配列番号1で表される塩基配列からなるDNA、(A) DNA comprising the base sequence represented by SEQ ID NO: 1,
(b)(a)の塩基配列からなるDNAと相補的な塩基配列からなるDNAとストリンジェントな条件下でハイブリダイズするDNAであって、アスペルギルス・オリゼ細胞株の融合効率を増加させる機能を有するタンパク質をコードするDNA、(B) DNA that hybridizes under stringent conditions with DNA consisting of a base sequence complementary to the DNA consisting of the base sequence of (a), and has the function of increasing the fusion efficiency of the Aspergillus oryzae cell line DNA encoding a protein,
(c)(a)の塩基配列からなるDNAと90%以上の配列相同性を示す塩基配列からなるDNAであって、アスペルギルス・オリゼ細胞株の融合効率を増加させる機能を有するタンパク質をコードするDNA、(C) a DNA comprising a nucleotide sequence having a sequence homology of 90% or more with the DNA comprising the nucleotide sequence of (a), which encodes a protein having a function of increasing the fusion efficiency of an Aspergillus oryzae cell line ,
(d)配列番号2で表されるアミノ酸配列からなるタンパク質をコードするDNA、又は(D) DNA encoding a protein consisting of the amino acid sequence represented by SEQ ID NO: 2, or
(e)(d)のアミノ酸配列において、1個若しくは数個のアミノ酸が欠失、置換、若しくは付加されたアミノ酸配列からなり、アスペルギルス・オリゼ細胞株の融合効率を増加させる機能を有するタンパク質をコードするDNA、(E) an amino acid sequence in which one or several amino acids are deleted, substituted or added in the amino acid sequence of (d), and encodes a protein having a function of increasing the fusion efficiency of an Aspergillus oryzae cell line DNA to
を含むプラスミドベクターでアスペルギルス・オリゼ細胞株を形質転換することによって、該細胞株における菌核形成促進因子SclRの発現を増加させる、請求項1に記載の方法。The method according to claim 1, wherein the expression of the nucleation promoting factor SclR in the cell line is increased by transforming an Aspergillus oryzae cell line with a plasmid vector comprising
MEA培地を用い25℃・暗所・通気条件下での対峙培養においてアスペルギルス・オリゼ細胞株(菌糸)の融合を行なわせる、請求項1又は2に記載の方法。 The method according to claim 1 or 2, wherein the Aspergillus oryzae cell line (mycelium) is fused in an opposing culture under a condition of 25 ° C, dark place and aeration using MEA medium. 更に、融合した細胞においては該表現型が相補されること、及び/又は、融合した細胞が2つの表現型を有することを基準として、融合細胞におけるヘテロカリオンの形成を同定することを含む、請求項1〜3のいずれかに記載の方法。 And further comprising identifying heterokaryon formation in the fused cell based on the phenotype being complemented in the fused cell and / or the fused cell having two phenotypes. Item 4. The method according to any one of Items 1 to 3. 表現型が形質転換マーカー及び/又は標識物質の発現に基づくものである、請求項1〜4のいずれかに記載の方法。 The method according to any one of claims 1 to 4, wherein the phenotype is based on expression of a transformation marker and / or a labeling substance. 形質転換マーカーに基づく表現型が栄養要求性である、請求項5に記載の方法。 6. The method of claim 5, wherein the phenotype based on the transformation marker is auxotrophic. 融合した細胞において該表現型が相補されることを寒天CD最少培地における培養によって確認する、請求項6に記載の方法。 The method according to claim 6, wherein the phenotype is complemented in the fused cells by culturing in an agar CD minimal medium. 標識物質が蛍光タンパク質である、請求項5に記載の方法。 The method according to claim 5, wherein the labeling substance is a fluorescent protein. 融合した細胞が2つの標識物質を有することを蛍光顕微鏡による核の観察によって確認する、請求項8に記載の方法。 The method according to claim 8, wherein the fused cells are confirmed to have two labeling substances by observing nuclei with a fluorescence microscope.
JP2012065157A 2012-03-22 2012-03-22 Efficient method for fusion of Neisseria gonorrhoeae cell lines Expired - Fee Related JP5995232B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012065157A JP5995232B2 (en) 2012-03-22 2012-03-22 Efficient method for fusion of Neisseria gonorrhoeae cell lines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012065157A JP5995232B2 (en) 2012-03-22 2012-03-22 Efficient method for fusion of Neisseria gonorrhoeae cell lines

Publications (2)

Publication Number Publication Date
JP2013192537A JP2013192537A (en) 2013-09-30
JP5995232B2 true JP5995232B2 (en) 2016-09-21

Family

ID=49392229

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012065157A Expired - Fee Related JP5995232B2 (en) 2012-03-22 2012-03-22 Efficient method for fusion of Neisseria gonorrhoeae cell lines

Country Status (1)

Country Link
JP (1) JP5995232B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6465470B2 (en) * 2014-01-22 2019-02-06 本田技研工業株式会社 Method for producing saccharifying enzyme, and method for saccharification of plant biomass
JP6360787B2 (en) * 2014-12-04 2018-07-18 本田技研工業株式会社 Neisseria gonorrhoeae mutants and transformants

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5367300B2 (en) * 2008-04-21 2013-12-11 公益財団法人野田産業科学研究所 Genes involved in conidia formation of Aspergillus and methods for increasing the conidia formation ability of Aspergillus oryzae

Also Published As

Publication number Publication date
JP2013192537A (en) 2013-09-30

Similar Documents

Publication Publication Date Title
Idnurm et al. A silver bullet in a golden age of functional genomics: the impact of Agrobacterium-mediated transformation of fungi
Zheng et al. Agrobacterium tumefaciens-mediated transformation as a tool for insertional mutagenesis in medicinal fungus Cordyceps militaris
JP7473137B2 (en) A novel strain of Pseudozyma antarctica
JP2007222055A (en) Method for preparing chromosome region deletion strain
KR20170121051A (en) Method for gene editing in microalgae using RGEN RNP
US20200040330A1 (en) Method for editing filamentous fungal genome through direct introduction of genome-editing protein
JP5995232B2 (en) Efficient method for fusion of Neisseria gonorrhoeae cell lines
JP6990111B2 (en) Method for producing mutant filamentous fungus
JP6599583B1 (en) Multigene disrupted Aspergillus microorganism and method for producing the same
CN108138173A (en) The manufacturing method of C4 dicarboxylic acids
CN115747229A (en) Heme biosensor-based growth coupling high-throughput screening method and application thereof in multi-gene metabolic pathway optimization
JP6944697B2 (en) Multi-step multi-mutant production method using genome editing in filamentous fungi
JP5367300B2 (en) Genes involved in conidia formation of Aspergillus and methods for increasing the conidia formation ability of Aspergillus oryzae
US20190002873A1 (en) Methods and compositions for creating altered and improved cells and organisms
WO2018190170A1 (en) Method for improving resistance to nitrate substrate analogue in microalga
TWI752396B (en) Genetically modified microorganism for improving the expression of itaconic acid and method for producing itaconic acid
JP7353602B1 (en) Genome editing method and composition for genome editing
JP7358105B2 (en) Pyrithiamine-resistant mutant strain of Aspergillus filamentous fungi
JP2012223137A (en) Nucleic acid encoding enzyme synthesizing starch of starch granule-bonded type, primer pair, inhibitor, and glutinous genus fagopyrum plant
JP4942030B2 (en) Genes, proteins, and recombinant vectors that increase gonococcal conidia formation
JP5785787B2 (en) Method for improving protoplast transformation efficiency
Oppelaar Targeted Mutagenesis of ELicitin Response (ELR) in Wild Solanum Species
JP5170397B2 (en) Method for producing mutant strains of filamentous fungi using ion beam irradiation
CN115948425A (en) Cordyceps militaris strain with enhanced white hair disease resistance created by CRISPR/Cas9 technology and method
JP4394925B2 (en) Method for producing site-specific genetically modified cells

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150317

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20150318

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160308

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20160427

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160610

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160726

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160817

R150 Certificate of patent or registration of utility model

Ref document number: 5995232

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees